ATR 10-Q Quarterly Report Sept. 30, 2018 | Alphaminr

ATR 10-Q Quarter ended Sept. 30, 2018

APTARGROUP INC
10-Qs and 10-Ks
10-Q
Quarter ended March 31, 2025
10-K
Fiscal year ended Dec. 31, 2024
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 28, 2025
DEF 14A
Filed on March 22, 2024
DEF 14A
Filed on March 24, 2023
DEF 14A
Filed on March 25, 2022
DEF 14A
Filed on March 26, 2021
DEF 14A
Filed on March 27, 2020
DEF 14A
Filed on March 22, 2019
DEF 14A
Filed on March 22, 2018
DEF 14A
Filed on March 22, 2017
DEF 14A
Filed on March 22, 2016
DEF 14A
Filed on March 24, 2015
DEF 14A
Filed on March 25, 2014
DEF 14A
Filed on March 26, 2013
DEF 14A
Filed on March 20, 2012
DEF 14A
Filed on March 18, 2011
DEF 14A
Filed on March 19, 2010
10-Q 1 atr-20180930x10q.htm 10-Q atr_Current folio_10Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO


COMMISSION FILE NUMBER 1-11846

ag_logo_rgb_k_cg10_5545_small  jpg

AptarGroup, Inc.

DELAWARE

36-3853103

(State of Incorporation)

(I.R.S. Employer Identification No.)

265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE, ILLINOIS 60014

815-477-0424

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☑ No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☑

Accelerated filer ☐

Non-accelerated filer ☐

Smaller reporting company ☐

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☑

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class

Outstanding at October 30, 2018

Common Stock, $.01 par value per share

62,814,068 shares


AptarGroup, Inc.

Form 10-Q

Quarter Ended September 30, 2018

INDEX

Part I.

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Statements of Income – Three and Nine Months Ended September 30, 2018 and 2017

1

Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended September 30, 2018 and 2017

2

Condensed Consolidated Balance Sheets – September 30, 2018 and December 31, 2017

3

Condensed Consolidated Statements of Changes in Equity – Three and Nine Months Ended September 30, 2018 and 2017

5

Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2018 and 2017

6

Notes to Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

31

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

47

Item 4.

Controls and Procedures

47

Part II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

48

Item 6.

Exhibits

49

Signature

50

i


PART I – FINANCIAL INFORMATIO N

ITEM 1.  FINANCIAL STATEMENTS (UNAUDITED )

AptarGroup, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF INCOM E

(Unaudited)

In thousands, except per share amounts

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Sales

$

665,775

$

624,326

$

2,079,733

$

1,843,388

Operating Expenses:

Cost of sales (exclusive of depreciation and amortization shown below)

435,379

407,781

1,355,445

1,192,129

Selling, research & development and administrative

103,574

95,536

323,146

292,274

Depreciation and amortization

41,857

40,087

123,133

114,660

Restructuring initiatives

23,852

48,002

604,662

543,404

1,849,726

1,599,063

Operating Income

61,113

80,922

230,007

244,325

Other (Expense) Income:

Interest expense

(8,735)

(9,733)

(24,754)

(25,707)

Interest income

1,537

1,113

6,306

2,086

Equity in results of affiliates

(45)

(72)

(130)

(142)

Miscellaneous, net

(2,928)

(2,712)

(4,372)

(1,996)

(10,171)

(11,404)

(22,950)

(25,759)

Income before Income Taxes

50,942

69,518

207,057

218,566

Provision for Income Taxes

11,920

15,989

52,966

48,043

Net Income

$

39,022

$

53,529

$

154,091

$

170,523

Net Income Attributable to Noncontrolling Interests

$

(26)

$

(6)

$

(20)

$

(6)

Net Income Attributable to AptarGroup, Inc.

$

38,996

$

53,523

$

154,071

$

170,517

Net Income Attributable to AptarGroup, Inc. per Common Share:

Basic

$

0.63

$

0.86

$

2.47

$

2.73

Diluted

$

0.60

$

0.83

$

2.38

$

2.64

Average Number of Shares Outstanding:

Basic

62,378

62,592

62,304

62,527

Diluted

65,129

64,821

64,822

64,626

Dividends per Common Share

$

0.34

$

0.32

$

0.98

$

0.96

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

1


AptarGroup, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOM E

(Unaudited)

In thousands

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Income

$

39,022

$

53,529

$

154,091

$

170,523

Other Comprehensive Income:

Foreign currency translation adjustments

(9,869)

17,903

(53,157)

69,505

Changes in treasury locks, net of tax

3

7

17

21

(Gain) loss on derivatives, net of tax

(1,166)

(3,591)

1,046

(3,591)

Defined benefit pension plan, net of tax

Amortization of prior service cost included in net income, net of tax

90

74

278

210

Amortization of net loss included in net income, net of tax

1,243

850

3,754

2,489

Total defined benefit pension plan, net of tax

1,333

924

4,032

2,699

Total other comprehensive (loss) income

(9,699)

15,243

(48,062)

68,634

Comprehensive Income

29,323

68,772

106,029

239,157

Comprehensive Income Attributable to Noncontrolling Interests

(15)

(11)

(4)

(18)

Comprehensive Income Attributable to AptarGroup, Inc.

$

29,308

$

68,761

$

106,025

$

239,139

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

2


AptarGroup, Inc.

CONDENSED CONSOLIDATED BALANCE SHEET S

(Unaudited)

In thousands

September 30,

December 31,

2018

2017

Assets

Current Assets:

Cash and equivalents

$

291,382

$

712,640

Accounts and notes receivable, less allowance for doubtful accounts of $2,702 in 2018 and $3,161 in 2017

580,450

510,426

Inventories

394,264

337,216

Prepaid and other

118,613

109,791

1,384,709

1,670,073

Property, Plant and Equipment:

Buildings and improvements

446,216

416,241

Machinery and equipment

2,352,421

2,237,655

2,798,637

2,653,896

Less: Accumulated depreciation

(1,842,885)

(1,811,819)

955,752

842,077

Land

25,355

25,829

981,107

867,906

Other Assets:

Investments in affiliates

19,143

9,444

Goodwill

699,330

443,887

Intangible assets

283,110

95,460

Miscellaneous

39,597

51,053

1,041,180

599,844

Total Assets

$

3,406,996

$

3,137,823

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

3


AptarGroup, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

In thousands, except share and per share amounts

September 30,

December 31,

2018

2017

Liabilities and Stockholders’ Equity

Current Liabilities:

Notes payable, including revolving credit facilities

$

153,236

$

4,336

Current maturities of long-term obligations, net of unamortized debt issuance costs

64,039

61,833

Accounts payable and accrued liabilities

524,528

461,579

741,803

527,748

Long-Term Obligations, net of unamortized debt issuance costs

1,131,737

1,191,146

Deferred Liabilities and Other:

Deferred income taxes

48,857

20,995

Retirement and deferred compensation plans

67,704

80,278

Deferred and other non-current liabilities

24,837

5,608

Commitments and contingencies

141,398

106,881

Stockholders’ Equity:

AptarGroup, Inc. stockholders’ equity

Common stock, $.01 par value, 199 million shares authorized, 67.2 and 66.7 million shares issued as of September 30, 2018 and December 31, 2017, respectively

672

667

Capital in excess of par value

670,710

609,471

Retained earnings

1,345,851

1,301,147

Accumulated other comprehensive (loss)

(301,348)

(253,302)

Less: Treasury stock at cost, 4.5 and 4.9 million shares as of September 30, 2018 and December 31, 2017, respectively

(324,141)

(346,245)

Total AptarGroup, Inc. Stockholders’ Equity

1,391,744

1,311,738

Noncontrolling interests in subsidiaries

314

310

Total Stockholders’ Equity

1,392,058

1,312,048

Total Liabilities and Stockholders’ Equity

$

3,406,996

$

3,137,823

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

4


AptarGroup, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUIT Y

(Unaudited)

In thousands

Three Months Ended

AptarGroup, Inc. Stockholders’ Equity

September 30, 2018 and 2017

Accumulated

Other

Common

Capital in

Non-

Retained

Comprehensive

Stock

Treasury

Excess of

Controlling

Total

Earnings

(Loss) Income

Par Value

Stock

Par Value

Interest

Equity

Balance - June 30, 2017

$

1,238,123

$

(266,325)

$

665

$

(257,731)

$

594,145

$

299

$

1,309,176

Net income

53,523

6

53,529

Foreign currency translation adjustments

17,898

5

17,903

Changes in unrecognized pension gains/losses and related amortization, net of tax

924

924

Changes in treasury locks, net of tax

7

7

Changes in derivative gains/losses, net of tax

(3,591)

(3,591)

Stock awards and option exercises

1

4,024

5,463

9,488

Cash dividends declared on common stock

(20,070)

(20,070)

Treasury stock purchased

(45,542)

(45,542)

Balance - September 30, 2017

$

1,271,576

$

(251,087)

$

666

$

(299,249)

$

599,608

$

310

$

1,321,824

Balance - June 30, 2018

$

1,328,034

$

(291,660)

$

668

$

(336,278)

$

646,449

$

299

$

1,347,512

Net income

38,996

26

39,022

Foreign currency translation adjustments

(9,858)

(11)

(9,869)

Changes in unrecognized pension gains/losses and related amortization, net of tax

1,333

1,333

Changes in treasury locks, net of tax

3

3

Changes in derivative gains/losses, net of tax

(1,166)

(1,166)

Stock awards and option exercises

4

12,137

24,261

36,402

Cash dividends declared on common stock

(21,179)

(21,179)

Balance - September 30, 2018

$

1,345,851

$

(301,348)

$

672

$

(324,141)

$

670,710

$

314

$

1,392,058

In thousands

Nine Months Ended

AptarGroup, Inc. Stockholders’ Equity

September 30, 2018 and 2017

Accumulated

Other

Common

Capital in

Non-

Retained

Comprehensive

Stock

Treasury

Excess of

Controlling

Total

Earnings

(Loss) Income

Par Value

Stock

Par Value

Interest

Equity

Balance - December 31, 2016

$

1,197,234

$

(319,709)

$

660

$

(250,917)

$

546,682

$

292

$

1,174,242

Net income

170,517

6

170,523

Foreign currency translation adjustments

69,493

12

69,505

Changes in unrecognized pension gains/losses and related amortization, net of tax

2,699

2,699

Changes in treasury locks, net of tax

21

21

Changes in derivative gains/losses, net of tax

(3,591)

(3,591)

Stock awards and option exercises

11

23,938

57,742

81,691

Cash dividends declared on common stock

(60,002)

(60,002)

Treasury stock purchased

(72,270)

(72,270)

Common stock repurchased and retired

(36,173)

(5)

(4,816)

(40,994)

Balance - September 30, 2017

$

1,271,576

$

(251,087)

$

666

$

(299,249)

$

599,608

$

310

$

1,321,824

Balance - December 31, 2017

$

1,301,147

$

(253,302)

$

667

$

(346,245)

$

609,471

$

310

$

1,312,048

Net income

154,071

20

154,091

Adoption of accounting standards

2,937

2,937

Foreign currency translation adjustments

(53,141)

(16)

(53,157)

Changes in unrecognized pension gains/losses and related amortization, net of tax

4,032

4,032

Changes in treasury locks, net of tax

17

17

Changes in derivative gains/losses, net of tax

1,046

1,046

Stock awards and option exercises

11

26,009

67,705

93,725

Cash dividends declared on common stock

(60,989)

(60,989)

Treasury stock purchased

(3,905)

(3,905)

Common stock repurchased and retired

(51,315)

(6)

(6,466)

(57,787)

Balance - September 30, 2018

$

1,345,851

$

(301,348)

$

672

$

(324,141)

$

670,710

$

314

$

1,392,058

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

5


AptarGroup, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW S

(Unaudited)

In thousands, brackets denote cash outflows

Nine Months Ended September 30,

2018

2017

Cash Flows from Operating Activities:

Net income

$

154,091

$

170,523

Adjustments to reconcile net income to net cash provided by operations:

Depreciation

113,555

107,017

Amortization

9,578

7,643

Stock-based compensation

14,829

15,005

Provision for doubtful accounts

190

124

Gain on disposition of fixed assets

(979)

67

Deferred income taxes

(5,414)

(2,265)

Defined benefit plan expense

14,466

12,932

Equity in results of affiliates

130

142

Changes in balance sheet items, excluding effects from acquisitions and foreign currency adjustments:

Accounts and other receivables

(72,620)

(46,038)

Inventories

(41,183)

(1,392)

Prepaid and other current assets

(807)

(10,839)

Accounts payable and accrued liabilities

55,921

49,158

Income taxes payable

(7,481)

2,061

Retirement and deferred compensation plan liabilities

(21,534)

(20,621)

Other changes, net

(3,157)

(18,355)

Net Cash Provided by Operations

209,585

265,162

Cash Flows from Investing Activities:

Capital expenditures

(145,321)

(120,803)

Proceeds from sale of property and equipment

4,056

2,345

Insurance proceeds

10,631

Settlement of derivative

(66,155)

Acquisition of business, net of cash acquired

(527,916)

Acquisition of intangible assets

(346)

Investment in unconsolidated affiliate

(10,000)

(5,000)

Notes receivable, net

216

451

Net Cash (Used) by Investing Activities

(668,680)

(189,162)

Cash Flows from Financing Activities:

Proceeds from notes payable

18,003

Repayments of notes payable

(6,395)

Proceeds and repayments of short term credit facility, net

139,384

(63,905)

Proceeds from long-term obligations

10,092

625,525

Repayments of long-term obligations

(67,026)

(4,836)

Dividends paid

(60,989)

(60,002)

Credit facility costs

(2,937)

Proceeds from stock option exercises

78,896

66,686

Purchase of treasury stock

(3,905)

(72,270)

Common stock repurchased and retired

(57,787)

(40,994)

Net Cash Provided by Financing Activities

50,273

447,267

Effect of Exchange Rate Changes on Cash

(7,436)

29,112

Net (Decrease) Increase in Cash and Equivalents and Restricted Cash

(416,258)

552,379

Cash and Equivalents and Restricted Cash at Beginning of Period

712,640

466,287

Cash and Equivalents and Restricted Cash at End of Period

$

296,382

$

1,018,666

Restricted cash included in the line item prepaid and other on the Condensed Consolidated Balance Sheets as shown below represents amounts held in escrow related to the CSP Technologies acquisition.

Nine Months Ended September 30,

2018

2017

Cash and equivalents

$

291,382

$

1,018,666

Restricted cash included in prepaid and other

5,000

Total Cash and Equivalents and Restricted Cash shown in the Statement of Cash Flows

$

296,382

$

1,018,666

See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.

6


AptarGroup, Inc.

Notes to Condensed Consolidated Financial Statement s

(Dollars in Thousands, Except per Share Amounts, or as Otherwise Indicated)

(Unaudited)

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries.  The terms “AptarGroup”, “Aptar” or “Company” as used herein refer to AptarGroup, Inc. and our subsidiaries.  All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation.

In the opinion of management, the unaudited Condensed Consolidated Financial Statements (the “Condensed Consolidated Financial Statements”) include all normal recurring adjustments necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented.  The accompanying Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading.  Also, certain financial position data included herein was derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 but does not include all disclosures required by U.S. GAAP.  Accordingly, these Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year.

During the quarter ended June 30, 2018, primarily based on published estimates, which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina has become a highly inflationary economy. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Local currency monetary assets and liabilities have been remeasured into U.S. dollars using exchange rates as of the latest balance sheet date, with remeasurement adjustments and other transaction gains and losses recognized in net earnings. During the third quarter of 2018, we recognized approximately $1.0 million of additional losses due to these changes. Our Argentinian operations contributed approximately 2.0% of consolidated net assets and revenues at and for the nine months ended September 30, 2018.

ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification.

In May 2014, the FASB issued ASU 2014-09, which amended the guidance for recognition of revenue from customer contracts.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  On January 1, 2018, we adopted this standard and all the related amendments (the “new revenue standard”) for all contracts.  This adoption was accounted for using the modified retrospective method.  We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the January 1, 2018 opening balance of retained earnings.  Comparative information for the prior periods has not been restated and continues to be reported under the accounting standards in effect prior to January 1, 2018.

Balance at

Balance at

December 31, 2017

Adjustment

January 1, 2018

Consolidated Balance Sheets

Assets

Inventories

$

337,216

$

(14,637)

$

322,579

Prepaid and other

109,791

13,984

123,775

Liabilities

Accounts payable and accrued liabilities

461,579

(5,706)

455,873

Deferred income taxes

20,995

1,292

22,287

Deferred and other non-current liabilities

5,608

824

6,432

Stockholders’ Equity

Retained earnings

1,301,147

2,937

1,304,084

7


A majority of our sales revenue continues to be recognized when products are shipped from our manufacturing facilities.  For certain custom product and tooling sales where revenue was previously recognized when the products were shipped, we now recognize revenue over the time required to manufacture the product or build the tool in accordance with the new revenue standard.  We also have certain extended warranty contracts, which under the new standard are considered a separate performance obligation and are required to be deferred and recognized into revenue over the life of the agreement.

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated statements of income and balance sheets is as follows:

For the Three Months Ended September 30, 2018

Balances

Without

Effect of

As

Adoption of

Change

Reported

ASC 606

Higher/(Lower)

Consolidated Statements of Income

Net Sales

Beauty + Home

$

341,760

$

340,787

$

973

Pharma

227,515

227,526

(11)

Food + Beverage

96,500

96,478

22

Costs and Expenses

Cost of sales (exclusive of depreciation and amortization)

435,379

434,601

778

Provision for income taxes

11,920

11,866

54

Net income

39,022

38,870

152

For the Nine Months Ended September 30, 2018

Balances

Without

Effect of

As

Adoption of

Change

Reported

ASC 606

Higher/(Lower)

Consolidated Statements of Income

Net Sales

Beauty + Home

$

1,088,469

$

1,087,922

$

547

Pharma

698,851

699,299

(448)

Food + Beverage

292,413

292,437

(24)

Costs and Expenses

Cost of sales (exclusive of depreciation and amortization)

1,355,445

1,354,844

601

Provision for income taxes

52,966

53,138

(172)

Net income

154,091

154,445

(354)

September 30, 2018

Balances

Without

Effect of

As

Adoption of

Change

Reported

ASC 606

Higher/(Lower)

Consolidated Balance Sheets

Assets

Inventories

$

394,264

$

409,502

$

(15,238)

Prepaid and other

118,613

102,767

15,846

Liabilities

Accounts payable and accrued liabilities

524,528

528,081

(3,553)

Deferred income taxes

48,857

47,737

1,120

Deferred and other non-current liabilities

24,837

24,379

458

Stockholders’ Equity

Retained earnings

1,345,851

1,343,268

2,583

8


In January 2016, the FASB issued ASU 2016-01, which provides guidance on the classification and measurement of financial assets and liabilities (equity securities and financial liabilities) under the fair value option and the presentation and disclosure requirements for financial instruments. In February 2018, ASU 2018-03 was issued to clarify certain aspects of the guidance issued in January 2016. The guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any related changes in fair value in net income unless the investments qualify for the new practicality exception. A measurement alternative exists for those equity investments that do not have a readily determinable fair value. These investments may be measured at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.  The standard also includes a new impairment model for equity investments without readily determinable fair values. The new model is a single-step model under which the Company is required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative assessment indicates that an impairment exists, the Company will estimate the fair value of the investment and recognize in current earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017.  The Company adopted the requirements of this standard during the first quarter of 2018.

In February 2016, the FASB issued ASU 2016-02 and subsequent amendments, which requires organizations to recognize leases on the balance sheet, and disclose key information about leasing arrangements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and recognition of expense in the income statement. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. We expect to adopt the new standard on its effective date. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. We expect to adopt the new standard on January 1, 2019 and use the effective date (option 1) as our date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The new standard also provides practical expedients for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. While we continue to assess all of the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our operating leases and the significant new disclosures about our leasing activities.

In August 2016, the FASB issued ASU 2016-15, which provides guidance on the classification of certain cash receipts and cash payments within the statement of cash flows.  This guidance provides clarification for the following types of transactions: debt prepayment or extinguishment costs, settlement of zero-coupon debt instruments or other debt instruments with coupon rates that are insignificant in relation to the effective interest rate of the borrowing, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, proceeds from the settlement of corporate-owned life insurance, distributions received from equity method investees and beneficial interest in securitization transactions. The guidance also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. However, early adoption was permitted and an entity that elects early adoption must adopt all of the amendments on a retrospective basis in the period of adoption. The Company adopted this standard in the fourth quarter of 2017.

In November 2016, the FASB issued ASU 2016-18, which provides guidance to address the diversity in the classification and presentation of changes in restricted cash on the statement of cash flows.  The amendments in this standard require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.  The new standard is effective for fiscal years and interim periods beginning after December 15, 2017.  The Company adopted the requirements of this standard during the first quarter of 2018 and appropriate disclosures are included on the statement of cash flows to the extent applicable.

9


In January 2017, the FASB issued ASU 2017-01, which provides guidance to clarify the definition of a business to assist entities in evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments in this standard provide a screen to determine when an integrated set of assets and activities (collectively referred to as a “set”) is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. If the screen is not met, the amendments in this update (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments also narrow the definition of the term “output” so that the term is consistent with how outputs are described in the new guidance for revenue recognition. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017.  The Company adopted the requirements of this standard during the first quarter of 2018.

In March 2017, the FASB issued ASU 2017-07, which provides guidance to disaggregate the current service cost component from the other components of net periodic benefit costs.  The service cost component should be presented within compensation costs while the other components should be presented outside of income from operations. The guidance also clarifies that only the service cost component is eligible for capitalization.  The new standard is effective for fiscal years and interim periods beginning after December 15, 2017.  The Company adopted the requirements of this standard during the first quarter of 2018 and the prior periods were restated as follows:

Original

Revised

Balance

Adjustment

Balance

Revised Condensed Consolidated Statements of Income

Three Months Ended September 30, 2017

Cost of sales (exclusive of depreciation and amortization)

$

408,081

$

(300)

$

407,781

Selling, research & development and administrative

95,748

(212)

95,536

Total Operating Expenses

543,916

(512)

543,404

Operating Income

80,410

512

80,922

Miscellaneous, net

(2,200)

(512)

(2,712)

Total Other (Expense) Income

(10,892)

(512)

(11,404)

Income before Income Taxes

69,518

69,518

Nine Months Ended September 30, 2017

Cost of sales (exclusive of depreciation and amortization)

$

1,192,967

$

(838)

$

1,192,129

Selling, research & development and administrative

292,923

(649)

292,274

Total Operating Expenses

1,600,550

(1,487)

1,599,063

Operating Income

242,838

1,487

244,325

Miscellaneous, net

(509)

(1,487)

(1,996)

Total Other (Expense) Income

(24,272)

(1,487)

(25,759)

Income before Income Taxes

218,566

218,566

In May 2017, the FASB issued ASU 2017-09, which provides clarification on applying the standards for stock compensation accounting.  The new standard provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.  The new standard is effective for fiscal years and interim periods beginning after December 15, 2017.  The Company adopted the requirements of this standard during the first quarter of 2018.

In August 2017, the FASB issued ASU 2017-12, which provides new guidance to improve the accounting for hedging activities.  The guidance changes the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the guidance makes certain targeted improvements to simplify the application of the hedge accounting guidance in current U.S. GAAP. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years.  However, early application is permitted in any interim period after the issuance of this guidance.  The Company adopted this standard in the third quarter of 2017.  See details in Note 9 – Derivative Instruments and Hedging Activities.

Other accounting standards that have been issued by the FASB or other standards-setting bodies did not have a material impact on our Condensed Consolidated Financial Statements.

10


RETIREMENT OF COMMON STOCK

During the first nine months of 2018, the Company repurchased 668 thousand shares of common stock, of which 623 thousand shares were immediately retired.  During the first nine months of 2017, the Company repurchased 1.4 million shares of common stock, of which 512 thousand shares were immediately retired.  Common stock was reduced by the number of shares retired at $0.01 par value per share.  The Company allocates the excess purchase price over par value between additional paid-in capital and retained earnings.

INCOME TAXES

The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned.  The income tax rates imposed by these taxing authorities may vary substantially.  Taxable income may differ from pre-tax income for financial accounting purposes.  To the extent that these differences create temporary differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made.

The Tax Cuts and Jobs Act (the “TCJA”) was enacted in the United States on December 22, 2017. The TCJA lowered the corporate tax rate from 35.0% to 21.0% and imposed a one-time transition tax on unremitted earnings as of the end of 2017, and featured many other tax law provisions.  New provisions for 2018 include, most notably, a tax on global intangible low-taxed income (“GILTI”) and the base erosion anti-abuse tax (“BEAT”), repeal of the domestic manufacturing deduction and limitations on the deductibility of executive compensation.  The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the U.S. GAAP application of the TCJA.  SAB 118 provides us up to a year to finalize accounting for the impacts of the TCJA.

The Company estimated provisional tax amounts related to the transition tax and components of the revaluation of deferred tax assets and liabilities for the period ended December 31, 2017.  This resulted in the recognition of a net tax charge of approximately $24.8 million, comprised of a provisional charge of $31.6 million for the transition tax and a provisional benefit of $6.8 million related to the corporate rate change.  While our accounting for the enactment of the new U.S. tax legislation is not complete, during the three months ended September 30, 2018, we recognized a provisional, discrete $1.9 million net tax benefit, consisting of a provisional $2.8 million benefit related to the change in the corporate tax rate that was partially offset by a provisional $0.9 million charge for the transition tax liability. During the nine months ended September 30, 2018, we recognized $5.4 million in provisional, discrete net tax benefits, composed of the $2.8 million benefit for the change in corporate tax rate and a net $2.6 million decrease to our transition tax liability. The benefit for the lower transition tax liability reflects additional guidance issued by the U.S. Treasury during 2018.  The Company expects both provisional amounts to be finalized in the fourth quarter of 2018 when the 2017 U.S. tax return filings are completed. The Company has elected to account for the tax on GILTI as a period cost and not as a measure of deferred taxes in the current period.

All of the Company’s non-U.S. earnings are subject to U.S. taxation, either from the TCJA transition tax on accumulated non-U.S. earnings as of the end of 2017 or the GILTI provisions on non-U.S. earnings going forward.  The Company maintains its assertion that the cash and distributable reserves at its non-U.S. affiliates are indefinitely reinvested.  The Company will provide for the necessary withholding and local income taxes when management decides that an affiliate should make a distribution.  These decisions are made taking into consideration the financial requirements of the non-U.S. affiliates and the global cash management goals of the Company.

The Company provides a liability for the amount of unrecognized tax benefits from uncertain tax positions.  This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition.  See Note 5 - Income Taxes for more information.

NOTE 2 – REVENUE

At contract inception, Aptar assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promise to transfer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, the Company considers all the goods or services promised in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized when (or as) the performance obligations are satisfied (i.e., when the customer obtains control of the good or service).  The majority of the Company’s revenues are derived from product and tooling sales; however Aptar also receives revenues from service, license, exclusivity and royalty arrangements, which are considered insignificant.  Revenue by segment and geography for the three and nine months ended September 30, 2018 is as follows:

11


For the Three Months Ended September 30, 2018

Latin

Segment

Europe

Domestic

America

Asia

Total

Beauty + Home

$

190,267

$

83,353

$

44,653

$

23,487

$

341,760

Pharma

161,733

50,126

6,165

9,491

227,515

Food + Beverage

29,472

47,870

7,476

11,682

96,500

Total

$

381,472

$

181,349

$

58,294

$

44,660

$

665,775

For the Nine Months Ended September 30, 2018

Latin

Segment

Europe

Domestic

America

Asia

Total

Beauty + Home

$

622,184

$

252,709

$

140,238

$

73,338

$

1,088,469

Pharma

520,574

132,496

19,229

26,552

698,851

Food + Beverage

90,185

143,005

23,343

35,880

292,413

Total

$

1,232,943

$

528,210

$

182,810

$

135,770

$

2,079,733

Aptar performs its obligations under a contract with a customer by transferring goods and/or services in exchange for consideration from the customer. The timing of performance will sometimes differ from the timing of the receipt of the associated consideration from the customer, thus resulting in the recognition of a contract asset or a contract liability. Aptar recognizes a contract asset when it transfers control of goods or services to a customer prior to invoicing for the related performance obligation. The contract asset is transferred to accounts receivable when the product is shipped and invoiced to the customer. Aptar recognizes a contract liability if the customer's payment of consideration precedes the entity's performance.

The opening and closing balances of Aptar’s contract asset and contract liabilities are as follows:

Balance as of

Balance as of

January 1, 2018

September 30, 2018

Increase/

(opening)

(closing)

(Decrease)

Contract asset (current)

$

13,984

$

15,846

$

1,862

Contract asset (long-term)

$

$

$

Contract liability (current)

$

15

$

413

$

398

Contract liability (long-term)

$

824

$

458

$

(366)

The differences in the opening and closing balances of the Company’s contract asset and contract liabilities are primarily the result of timing differences between the Company’s performance and the customer’s payment. The amount of revenue recognized in the current year that was included in the opening contract liability balance was $154 thousand.

Determining the Transaction Price

In most cases, the transaction price for each performance obligation is stated in the contract. In determining the variable amounts of consideration within the transaction price (such as volume-based customer rebates), Aptar includes an estimate of the expected amount of consideration as revenue. Aptar applies the expected value method based on all of the information (historical, current, and forecast) that is reasonably available and identifies reasonable estimates based on this information. The Company applies the method consistently throughout the contract when estimating the effect of an uncertainty on the amount of variable consideration to which it will be entitled.

Point in Time Performance Obligations

For product and tooling sales considered to be point in time, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. For free on board (“FOB”) shipping point terms, revenue is recognized at the time of shipment. The performance obligation with respect to the sale of goods is satisfied at the time of shipment because the customer gains control at that time. Once the goods are shipped, the Company is precluded from redirecting the shipment to another customer. With respect to FOB destination sales, shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfilment activities and are accounted for as fulfilment costs and revenue is recorded upon final delivery to the customer location.

12


Over Time Performance Obligations

For performance obligations related to manufacturing of highly customized products that have no alternative use to the Company and for which the Company has an enforceable right to payment for performance completed to date, the Company transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the Output Method based on the number of products produced. For similar performance obligations related to our tooling sales, the Company transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the Input Method based on costs incurred relative to total estimated costs to completion.  We believe these measurements provide a faithful depiction of the transfer of goods as the costs incurred reflect the value of the products produced.

Product Sales

Aptar primarily manufactures dispensing systems for our Beauty + Home, Pharma, and Food + Beverage customers. The amount of consideration is typically fixed for such customers. At the time of delivery, the customer is invoiced the agreed-upon price. Revenue from product sales is typically recognized upon manufacture or shipment, when control of the goods transfers to the customer.

To determine when the control transfers, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. A majority of product sales are sold FOB shipping point. For FOB shipping point shipments, control of the goods transfers to the customer at the time of shipment of the goods. Therefore, Aptar's performance obligation is satisfied at the time of shipment. Aptar has elected to account for shipping and handling costs that occur after the customer has obtained control of a good as fulfillment costs rather than as a promised service. Aptar does not have any material significant payment terms as payment is typically received shortly after the point of sale.

There also exist instances where Aptar manufactures highly customized products that have no alternative use to Aptar and for which Aptar has an enforceable right to payment for performance completed to date. For these products, the Company transfers control and recognizes revenue over time by measuring progress towards completion using the Output Method based on the number of products produced.  As we normally make our products to a customer’s order, the time between production and shipment of our products is typically within a few weeks.

As a part of its customary business practice, Aptar offers a standard warranty that the products will materially comply with the technical specifications and will be free from material defects. Because such warranties are not sold separately, do not provide for any service beyond a guarantee of a product’s initial specifications, and are not required by law, there is no revenue deferral for these types of warranties.

Tooling Sales

Aptar also builds or contracts for molds and other tools (collectively defined as “tooling”) necessary to produce our products. As with product sales, Aptar recognizes revenue when control of the tool transfers to the customer. If the tooling is highly customized with no alternative use to Aptar and Aptar has an enforceable right to payment for performance completed to date, the Company transfers control and recognizes revenue over time by measuring progress towards completion using the Input Method based on costs incurred relative to total estimated costs to completion. Otherwise, revenue for the tooling is recognized at the point in time when the customer approves the tool. Aptar does not have any material significant payment terms as payment is typically either received during the mold-build process or shortly after completion.

In certain instances, Aptar offers extended warranties on our tools above and beyond the normal standard warranties. Aptar normally receives payment at the inception of the contract and recognizes revenue over the term of the contract. At January 1, 2018, $839 thousand of unearned revenue associated with outstanding contracts was reported in Accounts Payable and Other Liabilities. At September 30, 2018, the unearned amount was $871 thousand. Aptar expects to recognize approximately $10 2 thousand of the unearned amount during the remainder of 2018, $367 thousand in 2019, and $402 thousand thereafter.

Contract Costs

Aptar does not incur material costs to obtain or fulfill revenue contracts.

Practical Expedients

Significant financing component: Aptar elected not to adjust the promised consideration for the time value of money for contracts where the difference between the time of payment and performance is one year or less.

Remaining performance obligations: Aptar elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. In addition, the Company has elected not to disclose the expected consideration related to performance obligations where the Company recognizes revenue in the amount it has a right to invoice (e.g., usage-based pricing terms).

13


NOTE 3 - INVENTORIES

Inventories, by component, consisted of:

September 30,

December 31,

2018

2017

Raw materials

$

111,985

$

99,196

Work in process

127,569

107,307

Finished goods

154,710

130,713

Total

$

394,264

$

337,216

NOTE 4 – GOODWILL AND OTHER INTANGIBLE ASSETS

The changes in the carrying amount of goodwill by reporting segment since December 31, 2017 are as follows:

Beauty +

Food +

Corporate

Home

Pharma

Beverage

& Other

Total

Goodwill

$

223,947

$

203,069

$

16,871

$

1,615

$

445,502

Accumulated impairment losses

(1,615)

(1,615)

Balance as of December 31, 2017

$

223,947

$

203,069

$

16,871

$

$

443,887

Acquisition

5,565

154,827

106,389

266,781

Foreign currency exchange effects

(4,853)

(6,237)

(248)

(11,338)

Goodwill

$

224,659

$

351,659

$

123,012

$

1,615

$

700,945

Accumulated impairment losses

(1,615)

(1,615)

Balance as of September 30, 2018

$

224,659

$

351,659

$

123,012

$

$

699,330

The table below shows a summary of intangible assets as of September 30, 2018 and December 31, 2017.

September 30, 2018

December 31, 2017

Weighted Average

Gross

Gross

Amortization Period

Carrying

Accumulated

Net

Carrying

Accumulated

Net

(Years)

Amount

Amortization

Value

Amount

Amortization

Value

Amortized intangible assets:

Patents

0.3

$

7,645

$

(7,535)

$

110

$

7,819

$

(7,806)

$

13

Acquired technology

13.5

93,171

(16,786)

76,385

47,571

(14,624)

32,947

Customer relationships

14.6

199,591

(18,162)

181,429

68,886

(13,401)

55,485

Trademarks and trade names

7.0

21,333

(5,311)

16,022

6,965

(4,485)

2,480

License agreements and other

9.3

19,808

(10,644)

9,164

14,862

(10,327)

4,535

Total intangible assets

13.2

$

341,548

$

(58,438)

$

283,110

$

146,103

$

(50,643)

$

95,460

Aggregate amortization expense for the intangible assets above for the quarters ended September 30, 2018 and 2017 was $4,005 and $2,708, respectively.  Aggregate amortization expense for the intangible assets above for the nine months ended September 30, 2018 and 2017 was $9,578 and $7,643, respectively.

Future estimated amortization expense for the years ending December 31 is as follows:

2018

$

6,023

(remaining estimated amortization for 2018)

2019

23,888

2020

22,786

2021

22,407

2022 and thereafter

208,006

14


Future amortization expense may fluctuate depending on changes in foreign currency rates.  The estimates for amortization expense noted above are based upon foreign exchange rates as of September 30, 2018.

NOTE 5 – INCOME TAXES

The TCJA was enacted in the U.S. on December 22, 2017. The TCJA lowered the corporate tax rate from 35.0% to 21.0% and imposed a one-time transition tax on unremitted earnings as of the end of 2017, among other changes.  New provisions for 2018 include, most notably, a tax on GILTI and BEAT, repeal of the domestic manufacturing deduction and limitations on the deductibility of executive compensation.  The SEC issued SAB 118 to address the U.S. GAAP application of the TCJA.  SAB 118 provides us up to a year to finalize accounting for the impacts of the TCJA.

The Company estimated provisional tax amounts related to the transition tax and components of the revaluation of deferred tax assets and liabilities for the period ended December 31, 2017.  This resulted in the recognition of a net tax charge of approximately $24.8 million, comprised of a provisional charge of $31.6 million for the transition tax and a provisional benefit of $6.8 million related to the corporate rate change.  While our accounting for the enactment of the new U.S. tax legislation is not complete, during the three months ended September 30, 2018, we recognized a provisional, discrete $1.9 million net tax benefit, consisting of a provisional $2.8 million benefit related to the change in the corporate tax rate that was partially offset by a provisional $0.9 million charge for the transition tax liability. During the nine months ended September 30, 2018, we recognized $5.4 million in provisional, discrete net tax benefits, comprised of the $2.8 million benefit for the change in corporate tax rate and a net $2.6 million decrease to our transition tax liability. The benefit for the lower transition tax liability reflects additional guidance issued by the U.S. Treasury during 2018.  The Company expects both provisional amounts to be finalized in the fourth quarter of 2018 when the 2017 U.S. tax return filings are completed. The Company has elected to account for the tax on GILTI as a period cost and not as a measure of deferred taxes in the current period.

The reported effective tax rate for the three months ended September 30, 2018 was 23.4%. The current year rate was favorably impacted by $4.5 million of tax benefits from employee share-based compensation along with a $1.9 million benefit from the TCJA provisional items (see above) and $3.5 million of refunds from the settlement of tax claims.  These favorable items were partially offset in the quarter by a $1.4 million impact of foreign valuation allowances, $1.5 million from the new U.S. tax provisions, including GILTI and BEAT and $4.0 million of other discrete and non-discrete tax items. The reported effective tax rate for the three months ended September 30, 2017 was 23.0%.  The prior year tax rate was favorably impacted by a $4.4 million benefit of refunds from the settlement of tax claims.

The reported effective tax rate for the nine months ended September 30, 2018 was 25.6%.   The tax rate was favorably impacted by $9.9 million of tax benefits from employee share-based compensation along with a $5.4 million benefit from the TCJA provisional items (see above) and $3.9 million of refunds from the settlement of tax claims.  These favorable items were partially offset by a $6.3 million impact from the new U.S. tax provisions, including GILTI and BEAT and $4.5 million of other discrete and non-discrete tax items. The reported effective tax rate for the nine months ended September 30, 2017 was 22.0%.  The prior year tax rate was favorably impacted by $8.8 million of tax benefits from employee share-based compensation, a $3.4 million net benefit from the settlement of tax claims and a $3.6 million benefit from repatriation activities to the U.S.

The Company had approximately $3.5 million and $3.1 million recorded for income tax uncertainties as of September 30, 2018 and December 31, 2017, respectively.  The uncertain amounts, if recognized, that would impact the effective tax rate are $3.5 million and $3.1 million, respectively. The Company estimates that it is reasonably possible that the liability for uncertain tax positions will decrease by no more than $1.5 million in the next twelve months from the resolution of various uncertain positions as a result of the completion of tax audits, litigation and the expiration of the statute of limitations in various jurisdictions.

15


-NOTE 6 – DEBT

At September 30, 2018, the Company’s long-term obligations consisted of the following:

Unamortized

Debt Issuance

Principal

Costs

Net

Notes payable 0.00% – 18.00%, due in monthly and annual installments through 2025

$

17,521

$

$

17,521

Senior unsecured notes 3.2%, due in 2022

75,000

94

74,906

Senior unsecured debts 3.6% floating, equal annual installments through 2022

224,000

578

223,422

Senior unsecured notes 3.5%, due in 2023

125,000

190

124,810

Senior unsecured notes 1.0%, due in 2023

116,095

456

115,639

Senior unsecured notes 3.4%, due in 2024

50,000

80

49,920

Senior unsecured notes 3.5%, due in 2024

100,000

190

99,810

Senior unsecured notes 1.2%, due in 2024

232,190

944

231,246

Senior unsecured notes 3.6%, due in 2025

125,000

215

124,785

Senior unsecured notes 3.6%, due in 2026

125,000

215

124,785

Capital lease obligations

8,932

8,932

$

1,198,738

$

2,962

$

1,195,776

Current maturities of long-term obligations

(64,039)

(64,039)

Total long-term obligations

$

1,134,699

$

2,962

$

1,131,737

At December 31, 2017, the Company’s long-term obligations consisted of the following:

Unamortized

Debt Issuance

Principal

Costs

Net

Notes payable 0.61% – 18.00%, due in monthly and annual installments through 2025

$

15,349

$

$

15,349

Senior unsecured notes 3.2%, due in 2022

75,000

113

74,887

Senior unsecured debts 2.6% floating, equal annual installments through 2022

280,000

692

279,308

Senior unsecured notes 3.5%, due in 2023

125,000

217

124,783

Senior unsecured notes 1.0%, due in 2023

120,095

526

119,569

Senior unsecured notes 3.4%, due in 2024

50,000

89

49,911

Senior unsecured notes 3.5%, due in 2024

100,000

217

99,783

Senior unsecured notes 1.2%, due in 2024

240,190

1,066

239,124

Senior unsecured notes 3.6%, due in 2025

125,000

238

124,762

Senior unsecured notes 3.6%, due in 2026

125,000

238

124,762

Capital lease obligations

741

741

$

1,256,375

$

3,396

$

1,252,979

Current maturities of long-term obligations

(61,833)

(61,833)

Total long-term obligations

$

1,194,542

$

3,396

$

1,191,146

Our revolving credit facility and corporate long-term obligations require us to satisfy certain financial and other covenants including:

Requirement

Level at September 30, 2018

Consolidated Leverage Ratio (1)

Maximum of 3.50 to 1.00

2.05 to 1.00

Consolidated Interest Coverage Ratio (1)

Minimum of 3.00 to 1.00

12.36 to 1.00


(1)

Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements.

16


During the third quarter of 2017, the Company entered into the borrowing arrangements summarized below through our wholly-owned United Kingdom  subsidiary to better balance our capital structure.

Debt Type

Amount

Term/Maturity

Interest Rate

Bank term loan

$

280,000

5 year amortizing/July 2022

2.56% floating swapped to 1.36% fixed

Bank revolver

150,000

5 year/July 2022

1.10% floating

Private placement

100,000

6 year/July 2023

0.98% fixed

Private placement

200,000

7 year/July 2024

1.17% fixed

The €150 million facility is available to the Company and €89.5 million was utilized as of September 30, 2018.  For the nine months ended September 30, 2018, the floating interest rate on the remaining $224 million of the original $280 million bank term loan was 3.60%.

The Company also maintains a 5-year revolving credit facility that provides for unsecured financing of up to $300 million and matures in July 2022. We had a $35.0 million outstanding balance under the credit facility at September 30, 2018. No balance was utilized as of December 31, 2017. Credit facility balances are included in Notes Payable, including revolving credit facilities on the Condensed Consolidated Balance Sheet.

Aggregate long-term maturities, excluding capital lease obligations, due annually from the current balance sheet date for the next five years are $62,477, $60,379, $58,316, $ 133,284, $117,219 and $758,131 thereafter.

NOTE 7 – RETIREMENT AND DEFERRED COMPENSATION PLANS

Components of Net Periodic Benefit Cost:

Domestic Plans

Foreign Plans

Three Months Ended September 30,

2018

2017

2018

2017

Service cost

$

2,853

$

2,426

$

1,457

$

1,447

Interest cost

1,713

1,752

445

459

Expected return on plan assets

(2,803)

(2,470)

(645)

(627)

Amortization of net loss

1,214

801

422

493

Amortization of prior service cost

122

104

Net periodic benefit cost

$

2,977

$

2,509

$

1,801

$

1,876

Domestic Plans

Foreign Plans

Nine Months Ended September 30,

2018

2017

2018

2017

Service cost

$

8,546

$

7,279

$

4,479

$

4,166

Interest cost

5,139

5,257

1,374

1,321

Expected return on plan assets

(8,409)

(7,409)

(1,982)

(1,781)

Amortization of net loss

3,642

2,403

1,301

1,400

Amortization of prior service cost

376

296

Net periodic benefit cost

$

8,918

$

7,530

$

5,548

$

5,402

The components of net periodic benefit cost, other than the service cost component, are included in the line “Miscellaneous, net” in the income statement.

EMPLOYER CONTRIBUTIONS

Although the Company has no minimum funding requirement, we contributed $20.0 million to our domestic defined benefit plans during the quarter ended September 30, 2018. We expect to contribute approximately $3.1 million to our foreign defined benefit plans in 2018, and as of September 30, 2018, we have contributed approximately $1.6 million of that amount.

17


NOTE 8 – ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in Accumulated Other Comprehensive (Loss) Income by Component:

Foreign

Defined Benefit

Currency

Pension Plans

Derivatives

Total

Balance -  December 31, 2016

$

(259,888)

$

(59,775)

$

(46)

$

(319,709)

Other comprehensive income (loss) before reclassifications

69,493

(9,237)

60,256

Amounts reclassified from accumulated other comprehensive income

2,699

5,667

8,366

Net current-period other comprehensive income

69,493

2,699

(3,570)

68,622

Balance -  September 30, 2017

$

(190,395)

$

(57,076)

$

(3,616)

$

(251,087)

Balance -  December 31, 2017

$

(185,503)

$

(64,595)

$

(3,204)

$

(253,302)

Other comprehensive income (loss) before reclassifications

(53,141)

12,507

(40,634)

Amounts reclassified from accumulated other comprehensive income

4,032

(11,444)

(7,412)

Net current-period other comprehensive income

(53,141)

4,032

1,063

(48,046)

Balance -  September 30, 2018

$

(238,644)

$

(60,563)

$

(2,141)

$

(301,348)

Reclassifications Out of Accumulated Other Comprehensive (Loss) Income:

Amount Reclassified from

Details about Accumulated Other

Accumulated Other

Affected Line in the Statement

Comprehensive Income Components

Comprehensive Income

Where Net Income is Presented

Three Months Ended September 30,

2018

2017

Defined Benefit Pension Plans

Amortization of net loss

$

1,636

$

1,294

(1)

Amortization of prior service cost

122

104

(1)

1,758

1,398

Total before tax

(425)

(474)

Tax benefit

$

1,333

$

924

Net of tax

Derivatives

Changes in treasury locks

$

4

$

11

Interest Expense

Changes in cross currency swap: interest component

(1,337)

(678)

Interest Expense

Changes in cross currency swap: foreign exchange component

(2,131)

7,481

Miscellaneous, net

(3,464)

6,814

Total before tax

588

(1,161)

Tax benefit

$

(2,876)

$

5,653

Net of tax

Total reclassifications for the period

$

(1,543)

$

6,577

18


Amount Reclassified from

Details about Accumulated Other

Accumulated Other

Affected Line in the Statement

Comprehensive Income Components

Comprehensive Income

Where Net Income is Presented

Nine Months Ended September 30,

2018

2017

Defined Benefit Pension Plans

Amortization of net loss

$

4,943

$

3,803

(1)

Amortization of prior service cost

376

296

(1)

5,319

4,099

Total before tax

(1,287)

(1,400)

Tax benefit

$

4,032

$

2,699

Net of tax

Derivatives

Changes in treasury locks

$

26

$

32

Interest Expense

Changes in cross currency swap: interest component

(3,824)

(678)

Interest Expense

Changes in cross currency swap: foreign exchange component

(9,984)

7,481

Miscellaneous, net

(13,782)

6,835

Total before tax

2,338

(1,168)

Tax benefit

$

(11,444)

$

5,667

Net of tax

Total reclassifications for the period

$

(7,412)

$

8,366


(1)

These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 7 – Retirement and Deferred Compensation Plans for additional details).

NOTE 9 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company maintains a foreign exchange risk management policy designed to establish a framework to protect the value of the Company’s non-functional denominated transactions from adverse changes in exchange rates.  Sales of the Company’s products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated.  Changes in exchange rates on such inter-country sales or intercompany loans can impact the Company’s results of operations.  The Company’s policy is not to engage in speculative foreign currency hedging activities, but to minimize our net foreign currency transaction exposure, defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency.  The Company may use foreign currency forward exchange contracts, options and cross currency swaps to economically hedge these risks.

For derivative instruments designated as hedges, the Company formally documents the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness at inception.  Quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item. Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur. All derivative financial instruments used as hedges are recorded at fair value in the Condensed Consolidated Balance Sheets (see Note 10 - Fair Value).

CASH FLOW HEDGE

For derivative instruments that are designated and qualify as cash flow hedges, the changes in fair values are recorded in accumulated other comprehensive loss and included in changes in derivative gain/loss. The changes in the fair values of derivatives designated as cash flow hedges are reclassified from accumulated other comprehensive loss to net income when the underlying hedged item is recognized in earnings. Cash flows from the settlement of derivative contracts designated as cash flow hedges offset cash flows from the underlying hedged items and are included in operating activities in the Condensed Consolidated Statements of Cash Flows.

19


As disclosed in Note 6 – Long-Term Obligations, our wholly-owned UK subsidiary borrowed $280 million in term loan borrowings under a new credit facility. In order to mitigate the currency risk of U.S. dollar debt on a euro functional currency entity and to mitigate the risk of variability in interest rates, we entered into a EUR/USD floating-to-fixed cross currency swap on July 20, 2017 in the notional amount of $280 million to effectively hedge the foreign exchange and interest rate exposure on the $280 million term loan.  Related to this hedge, approximately $2.1 million of net after-tax loss is included in accumulated other comprehensive earnings at September 30, 2018. The amount expected to be recognized into earnings during the next 12 months related to the interest component of our cross currency swap based on prevailing foreign exchange and interest rates at September 30, 2018 is $4.8 million. The amount expected to be recognized into earnings during the next 12 months related to the foreign exchange component of our cross currency swap is dependent on fluctuations in currency exchange rates.  As of September 30, 2018, the fair value of the cross currency swap was a $4.7 million liability. The swap contract expires on July 20, 2022.

HEDGE OF NET INVESTMENTS IN FOREIGN OPERATIONS

A significant number of the Company’s operations are located outside of the United States.  Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of the Company’s foreign subsidiaries.  A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on the Company’s financial condition and results of operations.  Conversely, a weakening U.S. dollar has an additive effect.  The Company in some cases maintains debt in these subsidiaries to offset the net asset exposure.  The Company does not otherwise actively manage this risk using derivative financial instruments.  In the event the Company plans on a full or partial liquidation of any of our foreign subsidiaries where the Company’s net investment is likely to be monetized, the Company will consider hedging the currency exposure associated with such a transaction.

OTHER

As of September 30, 2018, the Company has recorded the fair value of foreign currency forward exchange contracts of $0.3 million in prepaid and other and $0.9 million in accounts payable and accrued liabilities on the balance sheet.  All forward exchange contracts outstanding as of September 30, 2018 had an aggregate contract amount of $103.9 million.

Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017

September 30, 2018

December 31, 2017

Derivatives

Derivatives

Derivatives

not

Derivatives

not

Designated

Designated

Designated

Designated

Balance Sheet

as Hedging

as Hedging

as Hedging

as Hedging

Location

Instruments

Instruments

Instruments

Instruments

Derivative Assets

Foreign Exchange Contracts

Prepaid and other

$

$

262

$

$

663

$

$

262

$

$

663

Derivative Liabilities

Foreign Exchange Contracts

Accounts payable and accrued liabilities

$

$

881

$

$

1,604

Cross Currency Swap Contract (1)

Accounts payable and accrued liabilities

4,712

16,309

$

4,712

$

881

$

16,309

$

1,604


(1) This cross currency swap contract is composed of both an interest component and a foreign exchange component.

20


The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Quarters Ended September 30, 2018 and 2017

Amount of Gain (Loss)

Total Amount

Amount of Gain (Loss)

Location of (Loss)

Reclassified from

of Affected

Derivatives in Cash

Recognized in

Gain Recognized

Accumulated

Income

Flow Hedging

Other Comprehensive

in Income on

Other Comprehensive

Statement

Relationships

Income on Derivative

Derivatives

Income on Derivative

Line Item

2018

2017

2018

2017

Cross currency swap contract:

Interest component

$

(68)

$

(3,648)

Interest expense

$

1,337

$

678

$

(8,735)

Foreign exchange component

2,131

(7,481)

Miscellaneous, net

2,131

(7,481)

(2,928)

$

2,063

$

(11,129)

$

3,468

$

(6,803)

$

(11,663)

The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Nine Months Ended September 30, 2018 and 2017

Amount of Gain (Loss)

Total Amount

Amount of Gain (Loss)

Location of (Loss)

Reclassified from

of Affected

Derivatives in Cash

Recognized in

Gain Recognized

Accumulated

Income

Flow Hedging

Other Comprehensive

in Income on

Other Comprehensive

Statement

Relationships

Income on Derivative

Derivatives

Income on Derivative

Line Item

2018

2017

2018

2017

Cross currency swap contract:

Interest component

$

5,084

$

(3,648)

Interest expense

$

3,824

$

678

$

(24,754)

Foreign exchange component

9,984

(7,481)

Miscellaneous, net

9,984

(7,481)

(4,372)

$

15,068

$

(11,129)

$

13,808

$

(6,803)

$

(29,126)

The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Quarters Ended September 30, 2018 and 2017

Amount of (Loss) Gain

Derivatives Not Designated

Location of (Loss) Gain Recognized

Recognized in Income

as Hedging Instruments

in Income on Derivatives

on Derivatives

2018

2017

Foreign Exchange Contracts

Other (Expense) Income:
Miscellaneous, net

$

(1,011)

$

(15,534)

$

(1,011)

$

(15,534)

The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Nine Months Ended September 30, 2018 and 2017

Amount of (Loss) Gain

Derivatives Not Designated

Location of (Loss) Gain Recognized

Recognized in Income

as Hedging Instruments

in Income on Derivatives

on Derivatives

2018

2017

Foreign Exchange Contracts

Other (Expense) Income:
Miscellaneous, net

$

102

$

(64,651)

$

102

$

(64,651)

21


Gross Amounts not Offset

Gross Amounts

Net Amounts

in the Statement of

Offset in the

Presented in

Financial Position

Gross

Statement of

the Statement of

Financial

Cash Collateral

Net

Amount

Financial Position

Financial Position

Instruments

Received

Amount

Description

September 30, 2018

Derivative Assets

$

262

$

262

$

262

Total Assets

$

262

$

262

$

262

Derivative Liabilities

$

5,593

$

5,593

$

5,593

Total Liabilities

$

5,593

$

5,593

$

5,593

December 31, 2017

Derivative Assets

$

663

$

663

$

663

Total Assets

$

663

$

663

$

663

Derivative Liabilities

$

17,913

$

17,913

$

17,913

Total Liabilities

$

17,913

$

17,913

$

17,913

NOTE 10 – FAIR VALUE

Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities.  Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.  The three levels are defined as follows:

·

Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.

·

Level 2: Observable inputs other than those included in Level 1.  For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

·

Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.

As of September 30, 2018, the fair values of our financial assets and liabilities were categorized as follows:

Total

Level 1

Level 2

Level 3

Assets

Foreign exchange contracts (1)

$

262

$

$

262

$

Total assets at fair value

$

262

$

$

262

$

Liabilities

Foreign exchange contracts (1)

$

881

$

$

881

$

Cross currency swap contract (1)

4,712

4,712

Total liabilities at fair value

$

5,593

$

$

5,593

$

As of December 31, 2017, the fair values of our financial assets and liabilities were categorized as follows:

Total

Level 1

Level 2

Level 3

Assets

Foreign exchange contracts (1)

$

663

$

$

663

$

Total assets at fair value

$

663

$

$

663

$

Liabilities

Foreign exchange contracts (1)

$

1,604

$

$

1,604

$

Cross currency swap contract (1)

16,309

16,309

Total liabilities at fair value

$

17,913

$

$

17,913

$


(1)

Market approach valuation technique based on observable market transactions of spot and forward rates.

22


The carrying amounts of the Company’s other current financial instruments such as cash and equivalents, accounts and notes receivable, notes payable and current maturities of long-term obligations approximate fair value due to the short-term maturity of the instruments.  The Company considers our long-term obligations a Level 2 liability and utilizes the market approach valuation technique based on interest rates that are currently available to the Company for issuance of debt with similar terms and maturities. The estimated fair value of the Company’s long-term obligations was $1.1 billion as of September 30, 2018 and December 31, 2017. As discussed in Note 17 - Acquisitions, the Company has a contingent consideration obligation to the selling shareholders of Reboul SAS (“Reboul”) in connection with the Reboul Acquisition (as defined herein) based on 2018 earnings before net interest, taxes, depreciation and amortization (“EBITDA”).  We consider this a Level 3 liability; however, we estimated the aggregate fair value for this contingent consideration arrangement to be zero as of September 30, 2018.

NOTE 11 - COMMITMENTS AND CONTINGENCIES

The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature.  While management believes the resolution of these claims and lawsuits will not have a material adverse effect on the Company’s financial position or results of operations or cash flows, claims and legal proceedings are subject to inherent uncertainties, and unfavorable outcomes could occur and could include amounts in excess of any accruals which management has established.  Were such unfavorable final outcomes to occur, it is possible that they could have a material adverse effect on our financial position, results of operations and cash flows.

Under our Certificate of Incorporation, the Company has agreed to indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity.  The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a directors and officers liability insurance policy that covers a portion of our exposure.  As a result of our insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal.  The Company has no liabilities recorded for these agreements as of September 30, 2018 and December 31, 2017.

An environmental investigation, undertaken to assess areas of possible contamination, was completed at the Company’s facility in Jundiaí, São Paulo, Brazil.  The facility is primarily an internal supplier of anodized aluminum components for certain of our dispensing systems.  The testing indicated that soil and groundwater in certain areas of the facility were impacted above acceptable levels established by local regulations.  In March 2017, the Company reported the findings to the relevant environmental authority, the Environmental Company of the State of São Paulo (“CETESB”).  The Company continues to monitor and test the affected areas to determine the full extent of the impact and the scope of any required remediation.  Initial costs for further investigation and possible remediation, which are based on assumptions about the area of impact and customary remediation costs, are estimated to be in the range of $1.5 million to $3.0 million.  The range of possible loss associated with this environmental contingency is subject to considerable uncertainty due to the incomplete status of the investigation and ongoing review of the CETESB.  We will continue to evaluate the range of likely costs as the investigation proceeds and we have further clarity on the nature and extent of remediation that will be required.  We note that the contamination, or any failure to complete any required remediation in a timely manner, could potentially result in fines or penalties.  We accrued $1.5 million (operating expense) in the first quarter of 2017 relating to this contingency.  The amount is periodically reviewed, and adjusted as necessary, as the matter continues to evolve.  Based on the current status of the investigation, no adjustment to the accrual was necessary for the quarter ended September 30, 2018.  Also, during the quarter ended June 30, 2018, the Company recorded a $750 thousand accrual for a potential environmental matter at a U.S. manufacturing site.  This matter was remediated and settled during the third quarter of 2018 for $239 thousand.  The remaining accrual has been released during the third quarter of 2018.

NOTE 12 – STOCK REPURCHASE PROGRAM

On October 20, 2016, the Company announced a share repurchase authorization of up to $350 million of common stock.  This authorization replaces previous authorizations and has no expiration date.  Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.

During the nine months ended September 30, 2018, the Company repurchased approximately 668 thousand shares for approximately $61.7 million.  We did not repurchase any shares during the quarter ended September 30, 2018. During the three and nine months ended September 30, 2017, the Company repurchased approximately 546 thousand and 1.4 million shares for approximately $45.5 million and $113.3 million, respectively.  As of September 30, 2018, there was $80.2 million of authorized share repurchases available to the Company.

23


NOTE 13 – STOCK-BASED COMPENSATION

The Company issues stock options and restricted stock units (“RSUs”), which consist of time-based and performance-based awards, to employees under stock awards plans approved by stockholders.  In addition, RSUs are issued to non-employee directors under a Restricted Stock Unit Award Agreement for Directors pursuant to the 2018 Equity Incentive Plan. Previously, non-employee directors were issued stock options under a Director Stock Option Plan.  Stock options are awarded with the exercise price equal to the market price on the date of grant and generally vest over three years and expire 10 years after grant.

RSUs granted to employees vest according to a specified performance period and/or vesting period. Time-based RSUs generally vest over three years. Performance-based RSUs vest at the end of the specified performance period, generally three years, assuming required performance or market vesting conditions are met. Performance-based RSUs have one of two vesting conditions: (1) based on Aptar’s internal financial performance metrics and (2) based on Aptar’s total shareholder return (“TSR”) relative to total shareholder returns of an industrial peer group, subject to discretion if the overall TSR is negative at the conclusion of the performance period. At the time of vesting, Aptar will issue or cause to be issued in the employee’s name the vested shares of common stock. In addition, RSU awards are generally net settled (shares are withheld to cover the employee tax obligation). Director RSUs are only time-based, and generally vest over one year.

Compensation expense attributable to employee stock options for the first nine months of 2018 was approximately $8.9 million ($6.9 million after tax).  The income tax benefit related to this compensation expense was approximately $2.0 million.  Approximately $7.1 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.  Compensation expense attributable to stock options for the first nine months of 2017 was approximately $12.6 million ($8.6 million after tax).  The income tax benefit related to this compensation expense was approximately $4.0 million.  Approximately $11.0 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.

The Company uses historical data to estimate expected life and volatility.  The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.82 and $11.86 per share during the first nine months of 2018 and 2017, respectively.  These values were estimated on the respective grant dates using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Stock Awards Plans:

Nine Months Ended September 30,

2018

2017

Dividend Yield

1.5

%

1.7

%

Expected Stock Price Volatility

14.2

%

15.8

%

Risk-free Interest Rate

2.8

%

2.2

%

Expected Life of Option (years)

6.6

6.7

A summary of option activity under the Company’s stock plans during the nine months ended September 30, 2018 is presented below:

Stock Awards Plans

Director Stock Option Plans

Weighted Average

Weighted Average

Options

Exercise Price

Options

Exercise Price

Outstanding, January 1, 2018

8,059,319

$

61.67

214,967

$

57.44

Granted

603,901

88.39

Exercised

(1,439,333)

52.69

(57,767)

55.71

Forfeited or expired

(243,110)

74.32

Outstanding at September 30, 2018

6,980,777

$

65.39

157,200

$

58.08

Exercisable at September 30, 2018

5,114,822

$

60.65

157,200

$

58.08

Weighted-Average Remaining Contractual Term (Years):

Outstanding at September 30, 2018

6.0

4.3

Exercisable at September 30, 2018

5.2

4.3

Aggregate Intrinsic Value:

Outstanding at September 30, 2018

$

295,630

$

7,807

Exercisable at September 30, 2018

$

240,839

$

7,807

Intrinsic Value of Options Exercised During the Nine Months Ended:

September 30, 2018

$

62,895

$

2,187

September 30, 2017

$

44,734

$

1,995

24


The grant date fair value of options vested during the nine months ended September 30, 2018 and 2017 was $16.5 million and $16.9 million, respectively.  Cash received from option exercises was approximately $78.9 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $15.5 million in the nine months ended September 30, 2018.  As of September 30, 2018, the remaining valuation of stock option awards to be expensed in future periods was $10.7 million and the related weighted-average period over which it is expected to be recognized is 1.7 years.

The fair value of both time-based RSUs and performance-based RSUs pertaining to internal performance metrics is determined using the closing price of our common stock on the grant date. The fair value of performance-based RSUs pertaining to TSR is estimated using a Monte Carlo simulation. Inputs and assumptions used to calculate the fair value are shown in the table below.  The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement.

Nine Months Ended September 30,

2018

Fair value per stock award

$

128.70

Measurement date stock price

$

89.42

Assumptions:

Aptar's stock price expected volatility

12.30

%

Expected average volatility of peer companies

27.50

%

Correlation assumption

20.20

%

Risk-free interest rate

2.42

%

Dividend yield assumption

1.43

%

A summary of RSU activity as of September 30, 2018, and changes during the nine month period then ended, is presented below:

Time-Based RSUs

Performance-Based RSUs

Weighted Average

Weighted Average

Units

Grant-Date Fair Value

Units

Grant-Date Fair Value

Nonvested at January 1,  2018

124,067

$

74.65

$

Granted

187,502

96.26

80,843

111.55

Vested

(33,882)

75.57

Forfeited

(31,672)

78.62

(9,762)

111.55

Nonvested at September 30, 2018

246,015

$

90.48

71,081

$

111.55

Included in the September 30, 2018 time-based RSUs are 14,257 units awarded to non-employee directors and 14,793 units vested related to non-employee directors.

Compensation expense recorded attributable to RSUs for the first nine months of 2018 and 2017 was approximately $5.9 million and $2.4 million, respectively.  The actual tax benefit realized for the tax deduction from RSUs was approximately $718 thousand in the nine months ended September 30, 2018. The fair value of units vested during the nine months ended September 30, 2018 and 2017 was $2.6 million and $4.7 million, respectively.  The intrinsic value of units vested during the nine months ended September 30, 2018 and 2017 was $3.1 million and $5.2 million, respectively.  As of September 30, 2018, there was $23.2 million of total unrecognized compensation cost relating to RSU awards which is expected to be recognized over a weighted-average period of 2.4 years.

The Company has a long-term incentive program for certain employees.  Each award is based on the cumulative TSR of our common stock during a three-year performance period compared to a peer group.  The total expected expense related to this program for awards outstanding as of September 30, 2018 is approximately $3.7 million, of which $1.8 million and $1.5 million was recognized in the first nine months of 2018 and 2017, respectively.

25


NOTE 14 – EARNINGS PER SHARE

Basic net income per share is calculated by dividing net income attributable to Aptar by the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated by dividing the net income attributable to Aptar by the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to stock-based compensation awards. Stock-based compensation awards for which total employee proceeds exceed the average market price over the applicable period would have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share. The reconciliation of basic and diluted earnings per share for the three and nine months ended September 30, 2018 and 2017 is as follows:

Three Months Ended

September 30, 2018

September 30, 2017

Diluted

Basic

Diluted

Basic

Consolidated operations

Income available to common stockholders

$

38,996

$

38,996

$

53,523

$

53,523

Average equivalent shares

Shares of common stock

62,378

62,378

62,592

62,592

Effect of dilutive stock based compensation

Stock options

2,659

2,171

Restricted stock

92

58

Total average equivalent shares

65,129

62,378

64,821

62,592

Net income per share

$

0.60

$

0.63

$

0.83

$

0.86

Nine Months Ended

September 30, 2018

September 30, 2017

Diluted

Basic

Diluted

Basic

Consolidated operations

Income available to common stockholders

$

154,071

$

154,071

$

170,517

$

170,517

Average equivalent shares

Shares of common stock

62,304

62,304

62,527

62,527

Effect of dilutive stock-based compensation

Stock options

2,440

2,046

Restricted stock

78

53

Total average equivalent shares

64,822

62,304

64,626

62,527

Net income per share

$

2.38

$

2.47

$

2.64

$

2.73

NOTE 15 – SEGMENT INFORMATION

The Company is organized into three reporting segments.  Operations that sell dispensing systems and sealing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment.  Operations that sell dispensing systems, sealing and active packaging solutions primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.  Operations that sell dispensing systems and sealing solutions primarily to the food and beverage markets form the Food + Beverage segment. CSP Technologies’ financial results are reported in the Pharma and Food + Beverage segments. The accounting policies of the segments are the same as those described in Part II, Item 8, Note 1 - Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  In order to more closely align with how the markets analyze our segment results, we have changed our non-U.S. GAAP segment measure of profitability from Segment Income to Adjusted EBITDA beginning in 2018.  All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are now based on segment Adjusted EBITDA.  All references to segment profitability have been updated for this change.

26


Financial information regarding the Company’s reporting segments is shown below:

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Total Sales:

Beauty + Home

$

346,040

$

338,068

$

1,103,664

$

992,476

Pharma

227,691

199,551

699,105

598,168

Food + Beverage

97,297

91,852

294,362

269,159

Total Sales

671,028

629,471

2,097,131

1,859,803

Less: Intersegment Sales:

Beauty + Home

$

4,280

$

4,320

$

15,195

$

14,163

Pharma

176

4

254

7

Food + Beverage

797

821

1,949

2,245

Total Intersegment Sales

$

5,253

$

5,145

$

17,398

$

16,415

Net Sales:

Beauty + Home

$

341,760

$

333,748

$

1,088,469

$

978,313

Pharma

227,515

199,547

698,851

598,161

Food + Beverage

96,500

91,031

292,413

266,914

Net Sales

$

665,775

$

624,326

$

2,079,733

$

1,843,388

Adjusted EBITDA (1):

Beauty + Home

$

42,174

$

42,627

$

141,155

$

129,265

Pharma

84,516

66,260

250,709

204,750

Food + Beverage

15,482

18,116

46,284

49,756

Corporate & Other, unallocated

(7,954)

(8,778)

(28,576)

(26,924)

Acquisition-related costs (2)

(10,369)

(12,932)

Restructuring Initiatives (3)

(23,852)

(48,002)

Depreciation and amortization

(41,857)

(40,087)

(123,133)

(114,660)

Interest Expense

(8,735)

(9,733)

(24,754)

(25,707)

Interest Income

1,537

1,113

6,306

2,086

Income before Income Taxes

$

50,942

$

69,518

$

207,057

$

218,566


(1)

The Company evaluates performance of our business units and allocates resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs.

(2)

Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 17 – Acquisitions for further details).

(3)

Restructuring Initiatives includes expense items for the three and nine months ended September 30, 2018 as follows (see Note 18 – Restructuring Initiatives for further details):

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Restructuring Initiatives by Segment

Beauty + Home

$

18,854

$

$

38,501

$

Pharma

2,008

3,596

Food + Beverage

2,638

4,307

Corporate & Other

352

1,598

Total Restructuring Initiatives

$

23,852

$

$

48,002

$

Note 16 – INSURANCE SETTLEMENT RECEIVABLE

A fire caused damage to Aptar’s facility in Annecy, France in June 2016.  The fire was contained to one of three production units and there were no reported injuries. Aptar Annecy supplies anodized aluminum components for certain Aptar dispensing systems.  While repairs are underway, Aptar sources from its network of suppliers as well as from its anodizing facility in Brazil.  The Company is insured for the damages caused by the fire, including business interruption insurance, and it does not expect this incident to have a material impact on its financial results.

27


Losses related to the fire of $3.2 million and $14.1 million were incurred during the three and nine months ended September 30, 2018, respectively.  Losses related to the fire of $4.5 million and $14.4 million were incurred during the three and nine months ended September 30, 2017, respectively.  For the nine months ended September 30, 2018, we received insurance proceeds of $24.2 million, and have no insurance receivable as of September 30, 2018.  In many cases, our insurance coverage exceeds the amount of these recognized losses. However, no gain contingencies were recognized during the three or nine months ended September 30, 2018 as our ability to realize those gains remains uncertain.  Profitability was negatively impacted by $1.5 million and $4.4 million related to the Annecy fire during the three and nine months ended September 30, 2018, respectively.  These 2018 losses negatively impacted the Beauty + Home and Pharma segments by $0.5 million and $1.0 million, respectively, in the third quarter of 2018.  Profitability was negatively impacted by $1.4 million and $4.1 million related to the Annecy fire during the three and nine months ended September 30, 2017, respectively. These 2017 losses negatively impacted the Beauty + Home segment.

NOTE 17 – ACQUISITIONS

On August 27, 2018, the Company completed its acquisition (the “CSP Technologies Acquisition”) of all of the outstanding capital stock of CSP Technologies S.à r.l. (“CSP Technologies”).  CSP Technologies is a leader in active packaging technology based on proprietary material science expertise for the pharma and food service markets. CSP Technologies operates two manufacturing locations in the U.S. and one in France.  The purchase price was approximately $553.5 million and was funded by cash on hand. $5 million is currently held in restricted cash pending the finalization of a working capital adjustment expected to be completed within 75 days after closing.

CSP Technologies contributed net sales of $13.2 million and pretax loss of $1.9 million for the quarter ended September 30, 2018.  Sales of $9.4 million and $3.8 million were reported in the Pharma and Food + Beverage segments, respectively, for the quarter ended September 30, 2018.  Pretax losses of $1.8 million and $0.1 million were reported in the Pharma and Food + Beverage segments, respectively, for the quarter ended September 30, 2018. The pretax loss for the quarter includes $3.3 million of fair value adjustment amortization for inventory sold during the quarter.  The aforementioned purchase accounting adjustments and amounts included in the following tables are provisional, as the Company is in the process of finalizing purchase accounting.

The Company recognized $7.1 million and $9.0 million in transaction costs related to the acquisition of CSP Technologies for the three and nine months ended September 30, 2018, respectively.  These costs are reflected in the selling, research & development and administration section of the Consolidated Statements of Income and within Corporate & Other as disclosed in Note 15 – Segment Information.

The following table summarizes the assets acquired and liabilities assumed as of the acquisition date at estimated fair value.

August 27, 2018

Assets

Cash and equivalents

$

24,053

Accounts receivable

21,250

Inventories

45,500

Prepaid and other

2,925

Property, plant and equipment

101,579

Goodwill

261,216

Intangible assets

198,200

Other miscellaneous assets

980

Liabilities

Current maturities of long-term obligations

129

Accounts payable and accrued liabilities

30,871

Long-term obligations

6,037

Deferred income taxes

47,504

Retirement and deferred compensation plans

212

Deferred and other non-current liabilities

17,492

Net assets acquired

$

553,458

The following table is a summary of the fair value estimates of the acquired identifiable intangible assets and weighted-average useful lives as of the acquisition date:

28


Weighted-Average

Estimated

Useful Life

Fair Value

(in years)

of Asset

Acquired technology

12

$

46,700

Customer relationships

16

132,300

Trademarks and trade names

9

14,600

License agreements and other

9

4,600

Total

$

198,200

Goodwill in the amount of $261.2 million was recorded for the CSP Technologies Acquisition, of which $154.8 million and $106.4 million is included in the Pharma and Food + Beverage segments, respectively.  Goodwill is calculated as the excess of the consideration transferred over the net assets acquired and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Goodwill largely consists of leveraging the Company’s commercial presence in selling the CSP Technologies line of products in markets where CSP Technologies did not previously operate and the ability of CSP Technologies to maintain its competitive advantage from a technical viewpoint. Goodwill will not be amortized, but will be tested for impairment at least annually. We do not expect any of the goodwill will be deductible for tax purposes.

The unaudited pro forma results presented below include the effects of the CSP Technologies Acquisition as if it had occurred as of January 1, 2017. The unaudited pro forma results reflect certain adjustments related to the acquisition, such as intangible asset amortization, fair value adjustments for inventory and financing costs related to the change in our debt structure. Pro forma earnings were adjusted to exclude $14.2 million after tax ($18.5 million pretax) and $16.6 million after tax ($21.9 million pretax) of transaction and other costs for the three and nine months ended September 30, 2018, respectively. The aforementioned costs include compensation, consulting, legal and advisory fees. Pro forma earnings were also adjusted to exclude $2.6 million after tax ($3.3 million pretax) of nonrecurring expense related to the fair value adjustment to acquisition-date inventory for both the three and nine months ended September 30, 2018.

The pro forma results do not include any synergies or other expected benefits of the acquisition. Accordingly, the unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been completed on the date indicated.

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Sales

$

687,201

$

659,741

$

2,172,737

$

1,943,297

Net Income Attributable to AptarGroup Inc.

48,034

57,829

158,527

168,028

Net Income per common share — basic

0.77

0.92

2.54

2.69

Net Income per common share — diluted

0.74

0.89

2.45

2.60

On May 1, 2018, the Company acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets, for an initial purchase price of approximately $3.6 million (exclusive of $112 thousand of cash acquired) (the “Reboul Acquisition”). The results of Reboul’s operations have been included in the consolidated financial statements within our Beauty + Home segment since the date of acquisition. As part of the Reboul Acquisition, we may be obligated to pay to the selling shareholders of Reboul certain contingent consideration based on 2018 EBITDA as defined in the purchase agreement. Based on projections as of the acquisition date, we estimated the aggregate fair value for this contingent consideration arrangement to be zero.

In May 2018, the Company invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health, which is accounted for at cost, consistent with measurement alternative guidance described in Note 1 above. There were no indications of impairment nor were there any changes resulting from observable price changes noted in the three and nine months ended September 30, 2018.

In February 2017, the Company acquired a 20% minority investment in Kali Care, Inc. (“Kali Care”) for $5.0 million. Kali Care is a Silicon Valley-based technology company that provides digital monitoring systems for ophthalmic medication. Kali Care’s sensing technology allows clinicians to collect real-time compliance data, and is a powerful tool for ophthalmologists in managing the care of their patients, and represents an additional investment into connected devices for our Pharma applications.  This investment is being accounted for under the equity method of accounting from the date of acquisition.

29


NOTE 18 – RESTRUCTURING INITIATIVES

In late 2017, Aptar began a business transformation to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness.  The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions will also be addressed.  For the three and nine months ended September 30, 2018, the Company recognized $23.9 million and $48.0 million of restructuring costs related to this plan, respectively.  The Company estimates total implementation costs of approximately $90 million over the next three years. The Company also anticipates making capital investments related to the business transformation of approximately $54 million of which the majority will be in 2018.

As of September 30, 2018 the Company has recorded the following activity associated with the business transformation:

Beginning

Net Charges for

Ending

Reserve at

the Nine Months

Reserve at

12/31/2017

Ended 9/30/2018

Cash Paid

FX Impact

9/30/2018

Employee severance

$

2,258

$

2,035

$

(2,414)

$

(52)

$

1,827

Professional fees and other costs

45,967

(35,033)

637

11,571

Totals

$

2,258

$

48,002

$

(37,447)

$

585

$

13,398

30


ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

(AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS, OR AS OTHERWISE INDICATED)

RESULTS OF OPERATIONS

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net sales

100.0

%

100.0

%

100.0

%

100.0

%

Cost of sales (exclusive of depreciation and amortization shown below)

65.4

65.3

65.2

64.7

Selling, research & development and administrative

15.5

15.3

15.5

15.8

Depreciation and amortization

6.3

6.4

5.9

6.2

Restructuring initiatives

3.6

2.3

Operating income

9.2

13.0

11.1

13.3

Other expense

(1.5)

(1.9)

(1.1)

(1.4)

Income before income taxes

7.7

11.1

10.0

11.9

Net Income

5.9

8.6

7.4

9.3

Effective tax rate

23.4

%

23.0

%

25.6

%

22.0

%

Adjusted EBITDA margin (1)

20.2

%

18.9

%

19.7

%

19.4

%


(1)

Adjusted EBITDA margins are calculated as Adjusted EBITDA divided by Reported Net Sales.  See the reconciliation of non-U.S. GAAP measures starting on page 38.

NET SALES

We reported net sales of $665.8 million for the quarter ended September 30, 2018, which represents a 7% increase compared to $624.3 million reported during the third quarter of 2017. The average U.S. dollar exchange rate strengthened compared to most major currencies resulting in a negative currency translation impact of 3%.  The acquisitions of CSP Technologies and Reboul positively impacted sales by 3%. Therefore, core sales, which exclude acquisitions and changes in foreign currency rates, increased by 7% in the third quarter of 2018 compared to the third quarter of 2017.  The core sales growth reflected increased demand for products across all three of our reporting segments.  Core tooling sales increased $0.9 million during the quarter ended September 30, 2018 compared to the prior year as increased sales in the Beauty + Home segment were offset by lower tooling sales in the Pharma and Food + Beverage segments.

Third Quarter 2018

Beauty

Food +

Net Sales Change over Prior Year

+ Home

Pharma

Beverage

Total

Core Sales Growth

5

%

12

%

4

%

7

%

Acquisitions

1

%

5

%

4

%

3

%

Currency Effects (1)

(4)

%

(3)

%

(2)

%

(3)

%

Total Reported Net Sales Growth

2

%

14

%

6

%

7

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

For the first nine months of 2018, we reported net sales of $2.1 billion, 13% above the first nine months of 2017 reported net sales of $1.8 billion. The average U.S. dollar exchange rate weakened compared to the euro while the impact of several other major currencies on our business was mixed.  This resulted in a positive currency translation impact of 3%.  Sales were also positively impacted 1% by the acquisitions of CSP Technologies and Reboul. Therefore, core sales for the first nine months of 2018 increased 9% as all three segments reported strong growth over the first nine months of 2017.  Core sales were also positively impacted by higher tooling sales of $14.5 million for the first nine months of 2018 compared to the prior year mainly due to increased tooling sales in the Beauty + Home and Food + Beverage segments.

31


First Nine Months of 2018

Beauty

Food +

Net Sales Change over Prior Year

+ Home

Pharma

Beverage

Total

Core Sales Growth

8

%

11

%

6

%

9

%

Acquisitions

%

1

%

2

%

1

%

Currency Effects (1)

3

%

5

%

2

%

3

%

Total Reported Net Sales Growth

11

%

17

%

10

%

13

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

The following table sets forth, for the periods indicated, net sales by geographic location:

Three Months Ended September 30,

Nine Months Ended September 30,

2018

% of Total

2017

% of Total

2018

% of Total

2017

% of Total

Domestic

$

181,349

27%

$

164,345

26%

$

528,210

25%

$

484,984

26%

Europe

381,472

57%

350,631

56%

1,232,943

59%

1,057,841

57%

Latin America

58,294

9%

65,557

11%

182,810

9%

176,965

10%

Asia

44,660

7%

43,793

7%

135,770

7%

123,598

7%

For further discussion on net sales by reporting segment, please refer to the analysis of segment net sales and segment Adjusted EBITDA on the following pages.

COST OF SALES (EXCLUSIVE OF DEPRECIATION AND AMORTIZATION SHOWN BELOW)

Our cost of sales (“COS”) as a percent of net sales was 65.4% in the third quarter of 2018, nearly equal to 65.3% in the third quarter of 2017. While the mix of our product sales favored the higher margin Pharma products, our overall COS percentage was negatively impacted by higher material costs. During the quarter, we experienced increases in several raw material substrates, principally resin and metal. While the majority of our material cost increases can be passed along to our customers in our selling prices, we experience a lag in the timing of passing on these cost increases. The incremental business from our CSP Technologies acquisition also reported a higher COS percentage due to the effects of purchase accounting adjustments related to inventory, which further negatively impacted our overall COS percentage.

Cost of sales as a percent of net sales increased to 65.2% in the first nine months of 2018 compared to 64.7% in the same period a year ago.  As mentioned above, our COS percentage was negatively impacted by the timing delay of resin pass-throughs to our customers along with other material increases. We also had a higher COS percentage due to the mix of sales.  Historically, our tooling sales margins are lower than our product sales margins.  Therefore, the increase in tooling sales during the first nine months of 2018 negatively impacted our COS percentage.  We also reported a higher COS percentage related to some operational inefficiencies including start-up costs in our French anodizing facility along with the negative impact of purchase accounting adjustments related to our CSP Technologies and Reboul acquisitions during the first nine months of 2018 compared to the first nine months of 2017.

SELLING, RESEARCH & DEVELOPMENT AND ADMINISTRATIVE

Our selling, research & development and administrative expenses (“SG&A”) increased by approximately $8.0 million to $103.6 million in the third quarter of 2018 compared to $95.5 million during the same period in 2017. Excluding changes in foreign currency rates, SG&A increased by approximately $10.1 million in the quarter. The increase is mainly due to $7.1 million of one-time transaction costs and $1.9 million of operational costs related to our CSP Technologies acquisition during the third quarter of 2018. We also recognized increases in professional fees and higher personnel costs in accordance with our growth strategy.  SG&A as a percentage of net sales increased slightly to 15.5% compared to 15.3% in the same period of the prior year due to these acquisition costs and other cost increases mentioned above.

SG&A increased by $30.8 million to $323.1 million in the first nine months of 2018 compared to $292.3 million during the same period a year ago. Excluding changes in foreign currency rates, SG&A increased by approximately $21.1 million in the first nine months of 2018 compared to the first nine months of 2017.  As discussed above, the increase is related to $9.5 million of one-time acquisition-related costs, $1.9 million of operational cost related to our CSP Technologies acquisition along with higher professional fees and personnel costs related to our growth strategy. During 2018, we also recognized approximately $0.9 million of costs related to the write-down of an administrative building that is being held for sale, while in 2017 we recognized $1.5 million for the estimated costs to remediate environmental contamination found at the Company’s facility in Brazil. Although SG&A increased in amount, SG&A as a percentage of net sales decreased to 15.5% compared to 15.8% in the same period of the prior year due to the strong increase in sales.

32


DEPRECIATION AND AMORTIZATION

Reported depreciation and amortization expenses increased by approximately $1.8 million to $41.9 million in the third quarter of 2018 compared to $40.1 million during the same period a year ago. Excluding changes in foreign currency rates, depreciation and amortization increased by approximately $2.5 million in the quarter compared to the same period a year ago. This increase is mainly due to $2.1 million of incremental operational results and amortization of purchase accounting adjustments related to our CSP Technologies acquisition.  We also realized increased capital spending during the past year to support the growth in our business. Depreciation and amortization as a percentage of net sales decreased to 6.3% in the third quarter of 2018 compared to 6.4% in the same period of the prior year primarily due to the strong increase in sales.

For the first nine months of 2018, reported depreciation and amortization expenses increased by approximately $8.4 million to $123.1 million compared to $114.7 million in the first nine months of 2017. Excluding changes in foreign currency rates, depreciation and amortization increased by approximately $4.0 million compared to the same period a year ago. As discussed above, this increase is mainly due to $2.1 million of incremental costs related to our CSP Technologies acquisition and increased capital spending in the current year to support the growth in our business. Depreciation and amortization as a percentage of net sales decreased to 5.9% in the first nine months of 2018 compared to 6.2% in the same period of the prior year primarily due to the strong increase in sales.

RESTRUCTURING INITIATIVES

In late 2017, Aptar began a business transformation to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness.  The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions are also being addressed.  During the third quarter of 2018, we recognized approximately $23.9 million of restructuring costs related to this plan with approximately $18.9 million, $2.0 million, $2.6 million and $0.4 million being reported within the Beauty + Home segment, Pharma segment, Food + Beverage segment and Corporate & Other, respectively.  During the first nine months of 2018, we recognized approximately $48.0 million of restructuring costs related to this plan with approximately $38.5 million, $3.6 million, $4.3 million and $1.6 million being reported within the Beauty + Home segment, Pharma segment, Food + Beverage segment and Corporate & Other, respectively.  We estimate total implementation costs of approximately $90 million over the next three years, including costs that have been recognized to date. We also anticipate making capital investments related to the business transformation of approximately $54 million in 2018.  We expect this business transformation to yield annualized incremental EBITDA of approximately $80 million by the end of 2020, principally within the Beauty + Home segment.

OPERATING INCOME

Operating income decreased approximately $19.8 million in the third quarter of 2018 compared to the same period a year ago.  Excluding changes in foreign currency rates, operating income decreased by approximately $17.5 million in the quarter compared to the same period a year ago.  This decrease is due to $23.9 million of restructuring costs and $7.1 million of transaction costs related to our CSP Technologies acquisition, partially offset by the increase in profitability from the higher sales during the third quarter of 2018. Operating income as a percentage of net sales decreased to 9.2% in the third quarter of 2018 compared to 13.0% for the same period in the prior year due to these strategic investments.

For the first nine months of 2018, operating income decreased approximately $14.3 million to $230.0 million compared to $244.3 million in the same period of the prior year.  Excluding changes in foreign currency rates, operating income decreased by approximately $25.5 million in the first nine months of 2018 compared to the same period a year ago. As discussed above, this decrease is due to the $48.0 million of restructuring costs and $9.5 million of transaction costs related to our CSP Technologies and Reboul acquisitions, partially offset by increased profitability on higher sales reported during the first nine months of 2018.  Operating income as a percentage of net sales decreased to 11.1% in the first nine months of 2018 compared to 13.3% for the same period in the prior year mainly due to these costs.

NET OTHER EXPENSE

Net other expense in the third quarter of 2018 decreased $1.2 million to $10.2 million from $11.4 million in the same period of the prior year. For 2018, interest expense decreased by approximately $1.0 million mainly due to the prepayment of two of our higher interest private placement facilities during the fourth quarter of 2017 with cash available from our repatriation of foreign earnings to the U.S. during the third quarter of 2017.

Net other expenses for the nine months ended September 30, 2018 decreased $2.8 million to $23.0 million from $25.8 million in the same period of the prior year.  This decrease is mainly due to $4.2 million of higher interest income in 2018 on U.S. cash balances repatriated from Europe. However, in 2017 we realized $2.5 million of income on our forward exchange contracts due to the forward points in the currencies in which we were invested.

33


EFFECTIVE TAX RATE

The reported effective tax rate for the three months ended September 30, 2018 was 23.4%. The tax rate was favorably impacted by $4.5 million of tax benefits from employee share-based compensation along with a $1.9 million benefit from the Tax Cuts and Jobs Act (the “TCJA”) provisional items and $3.5 million of refunds from the settlement of tax claims.  These favorable items were partially offset in the quarter by a $1.4 million impact of foreign valuation allowances, $1.5 million for the new U.S. tax provisions, including the global intangible low-taxed income (“GILTI”) and base erosion anti-abuse tax (“BEAT”) tax, and $4.0 million of other discrete and non-discrete tax items. The reported effective tax rate for the three months ended September 30, 2017 was 23.0%.  The prior year tax rate was favorably impacted by a $4.4 million benefit of refunds from the settlement of tax claims.

The reported effective tax rate for the nine months ended September 30, 2018 was 25.6%. The tax rate was favorably impacted by $9.9 million of tax benefits from employee share-based compensation along with a $5.4 million benefit from the TCJA provisional items and $3.9 million of refunds from the settlement of tax claims.  These favorable items were partially offset by a $6.3 million impact of the new U.S. tax provisions, including GILTI and BEAT, and $4.5 million of other discrete and non-discrete tax items.  The reported effective tax rate for the nine months ended September 30, 2017 was 22.0%.  The prior year tax rate was favorably impacted by $8.8 million of tax benefits from employee share-based compensation, $3.4 million of net benefit from the settlement of tax claims and $3.6 million benefit of repatriation activities to the U.S.

NET INCOME ATTRIBUTABLE TO APTARGROUP, INC.

We reported net income attributable to AptarGroup of $39.0 million and $154.1 million in the three and nine months ended September 30, 2018, respectively, compared to $53.5 million and $170.5 million for the same periods in the prior year.

BEAUTY + HOME SEGMENT

Operations that sell dispensing systems and sealing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment.

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Sales

$

341,760

$

333,748

$

1,088,469

$

978,313

Adjusted EBITDA  (1)

42,174

42,627

141,155

129,265

Adjusted EBITDA margin  (1)

12.3%

12.8%

13.0%

13.2%


(1)

Adjusted EBITDA is calculated as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs.  Adjusted EBITDA margins are calculated as Adjusted EBITDA divided by Reported Net Sales.  See the reconciliation of non-U.S. GAAP measures starting on page 38.

Net sales for the quarter ended September 30, 2018 increased 2% to $341.8 million compared to $333.7 million in the third quarter of the prior year.  Incremental sales from our Reboul acquisition positively impacted sales by 1% while changes in currency rates negatively impacted net sales by 4%. Therefore, core sales increased 5% in the third quarter of 2018 compared to the same quarter of the prior year.  Geographically, core sales increased in all regions compared to the prior year quarter. We experienced strong core sales growth of 6% in our personal care and beauty markets while core home care sales declined by 2% compared to the prior year due to lower custom tooling sales.  The increase in personal care sales mainly relates to increased sales of our products used on body care applications and increased tooling sales. Increased sales to the beauty market mainly related to increased demand for our facial skin care dispensing solutions.

34


Third Quarter 2018

Personal

Home

Net Sales Change over Prior Year

Care

Beauty

Care

Total

Core Sales Growth

6

%

6

%

(2)

%

5

%

Acquisitions

%

2

%

%

1

%

Currency Effects (1)

(4)

%

(4)

%

(3)

%

(4)

%

Total Reported Net Sales Growth

2

%

4

%

(5)

%

2

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Net sales increased 11% in the first nine months of 2018 to $1.1 billion compared to $978.3 million in the first nine months of the prior year.  Changes in currency rates positively impacted net sales by 3%. Acquisitions were immaterial for the nine month period ended September 30, 2018. Therefore, core sales increased 8% in the first nine months of 2018 compared to the same period in the prior year.  Geographically, core sales increased in all regions compared to the prior year. Core sales were higher across all three markets as personal care, beauty and home care increased by 9%, 8% and 1%, respectively.  Strong sales in the facial skin care and body care applications along with higher tooling sales were responsible for the increase in sales for the first nine months of 2018 compared to 2017.

First Nine Months of 2018

Personal

Home

Net Sales Change over Prior Year

Care

Beauty

Care

Total

Core Sales Growth

9

%

8

%

1

%

8

%

Acquisitions

%

1

%

%

%

Currency Effects (1)

2

%

4

%

2

%

3

%

Total Reported Net Sales Growth

11

%

13

%

3

%

11

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Adjusted EBITDA in the third quarter of 2018 decreased 1% to $42.2 million compared to $42.6 million reported in the same period in the prior year.  Increases in product and tooling sales and an operational improvement in our European custom decorative packaging business were offset by large increases in both resin and metal costs.  We also experienced unfavorable currency impact on Argentina hyperinflation accounting and operating results related to our Reboul acquisition during the third quarter of 2018.

Adjusted EBITDA in the first nine months of 2018 increased 9% to $141.2 million compared to $129.3 million reported in the same period in the prior year.  Our increase in sales more than compensated for the increased resin and metal costs. The first nine months of 2017 also included $1.5 million of estimated costs to remediate environmental contamination found at the Company’s anodizing facility in Brazil.

PHARMA SEGMENT

Operations that sell dispensing systems, sealing and active packaging solutions primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Sales

$

227,515

$

199,547

$

698,851

$

598,161

Adjusted EBITDA  (1)

84,516

66,260

250,709

204,750

Adjusted EBITDA margin  (1)

37.1%

33.2%

35.9%

34.2%


(1)

Adjusted EBITDA is calculated as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs.  Adjusted EBITDA margins are calculated as Adjusted EBITDA divided by Reported Net Sales.  See the reconciliation of non-U.S. GAAP measures starting on page 38.

35


Net sales for the Pharma segment increased 14% in the third quarter of 2018 to $227.5 million compared to $199.5 million in the third quarter of 2017. Changes in currency negatively affected net sales by 3% while the acquisition of CSP Technologies positively impacted sales by 5% in the third quarter of 2018.  Therefore, core sales increased by 12% in the third quarter of 2018 compared to the third quarter of 2017. All three of our existing markets reported increased core sales over the prior year.  Core sales to the prescription market were particularly strong and increased 15% mainly driven by increased demand for our innovative nasal drug delivery systems for our central nervous system and allergic rhinitis treatments, which compensated for lower tooling sales. Sales to the consumer health care market increased 9% on strong demand for our ophthalmic and dermal treatments.  For the injectables market, core sales increased 7% primarily due to increased demand for components used in the administration of antithrombotic products to customers in Europe during the third quarter of 2018.

Third Quarter 2018

Prescription

Consumer

Active

Net Sales Change over Prior Year

Drug

Health Care

Injectables

Packaging

Total

Core Sales Growth

15

%

9

%

7

%

%

12

%

Acquisitions

%

%

%

100

%

5

%

Currency Effects (1)

(2)

%

(4)

%

(1)

%

%

(3)

%

Total Reported Net Sales Growth

13

%

5

%

6

%

100

%

14

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Net sales for the first nine months of 2018 increased by 17% to $698.9 million compared to $598.2 million in the first nine months of 2017.  Changes in currency rates positively impacted net sales by 5% in the first nine months of 2018 while the CSP Technologies acquisition contributed a 1% sales improvement.  Therefore, core sales increased by 11% in the first nine months of 2018 compared to the same period in the prior year. As discussed above, the prescription drug market reported a core sales increase of 10% on strong sales of our products sold for central nervous system and allergic rhinitis treatments. Core sales to the consumer health care market increased 15% on strong demand for our products used on decongestants and nasal salines. Core sales of our products to the injectables markets increased 6% due to strong sales of our injectable components used on vaccine products. Lower core tooling sales in prescription and consumer health care negatively impacted the segment’s reported sales by $2.5 million for the first nine months of 2018 compared to 2017.

First Nine Months of 2018

Prescription

Consumer

Active

Net Sales Change over Prior Year

Drug

Health Care

Injectables

Packaging

Total

Core Sales Growth

10

%

15

%

6

%

%

11

%

Acquisitions

%

%

%

100

%

1

%

Currency Effects (1)

5

%

3

%

6

%

%

5

%

Total Reported Net Sales Growth

15

%

18

%

12

%

100

%

17

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Adjusted EBITDA in the third quarter of 2018 increased 28% to $84.5 million compared to $66.3 million reported in the same period of the prior year.  The strong product sales across all three markets discussed above along with improved operational efficiencies led to the increase in reported results for the third quarter of 2018 compared to the third quarter of 2017.

Adjusted EBITDA in the first nine months of 2018 increased 22% to $250.7 million compared to $204.8 million reported in the same period of the prior year. The increased sales and improved operational efficiencies discussed above offset lower profitability on some tooling projects.

36


FOOD + BEVERAGE SEGMENT

Operations that sell dispensing systems and sealing solutions primarily to the food and beverage markets form the Food + Beverage segment.

Three Months Ended September 30,

Nine Months Ended September 30,

2018

2017

2018

2017

Net Sales

$

96,500

$

91,031

$

292,413

$

266,914

Adjusted EBITDA  (1)

15,482

18,116

46,284

49,756

Adjusted EBITDA margin  (1)

16.0%

19.9%

15.8%

18.6%


(1)

Adjusted EBITDA is calculated as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs. Adjusted EBITDA margins are calculated as Adjusted EBITDA divided by Reported Net Sales.  See the reconciliation of non-U.S. GAAP measures starting on page 38.

Net sales for the quarter ended September 30, 2018 increased approximately 6% to $96.5 million compared to $91.0 million in the third quarter of the prior year. Incremental sales from our CSP Technologies acquisition positively impacted sales by 4% while changes in foreign currency rates had an unfavorable impact of 2% on the total segment sales. Therefore, core sales increased by 4% in the third quarter of 2018 compared to the third quarter of 2017.  Core sales to the food market increased 14% while core sales to the beverage market decreased 8% in the third quarter of 2018 compared to the same period of the prior year.  For the food market, we recognized strong sales of our products to our infant nutrition customers along with higher tooling sales compared to the same period last year.  For the beverage market, an increase in product sales, mainly to our bottled water and juice customers, was more than offset by lower tooling sales which drove the lower core sales growth in the third quarter of 2018 compared to the prior year period.  For the segment, lower tooling sales of $1.0 million was compensated by a $2.2 million increase in the pass-through of resin price changes in the quarter ended September 30, 2018 compared to the third quarter of the prior year.

Third Quarter 2018

Net Sales Change over Prior Year

Food

Beverage

Total

Core Sales Growth

14

%

(8)

%

4

%

Acquisitions

5

%

%

4

%

Currency Effects (1)

(2)

%

(2)

%

(2)

%

Total Reported Net Sales Growth

17

%

(10)

%

6

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Net sales for the first nine months of 2018 increased by 10% to $292.4 million compared to $266.9 million in the first nine months of 2017.  Changes in currency rates and the CSP Technologies acquisition each positively impacted net sales by 2% in the first nine months of 2018.  Therefore, core sales increased by 6% in the first nine months of 2018 compared to the same period in the prior year.  Core sales to the food market increased 11% while core sales to the beverage market were flat compared to the first nine months of 2017.  Sales to the food market increased due to strong sales of our products to our infant nutrition complemented by strong increases in tooling sales.  For the beverage market, strong sales to our bottled water and juice customers were offset by a decrease in tooling sales and functional drink application sales, mainly in China. For the segment, sales for the first nine months of 2018 were favorably impacted by $7.6 million of higher core tooling sales along with a $6.0 million increase on the pass-through of resin price changes compared to the first nine months of 2017.

First Nine Months of 2018

Net Sales Change over Prior Year

Food

Beverage

Total

Core Sales Growth

11

%

%

6

%

Acquisitions

2

%

%

2

%

Currency Effects (1)

1

%

3

%

2

%

Total Reported Net Sales Growth

14

%

3

%

10

%


(1)

Currency effects are calculated by translating last year’s amounts at this year’s foreign exchange rates.

Adjusted EBITDA in the third quarter of 2018 decreased 15% to $15.5 million compared to $18.1 million reported in the same period of the prior year.  This decrease is mainly due to significant material cost increases along with lower profit on our tooling projects during the third quarter of 2018 compared to the third quarter of 2017.

37


Adjusted EBITDA in the first nine months of 2018 decreased 7% to $46.3 million compared to $49.8 million reported in the same period of the prior year.  As discussed above, our profitability was negatively impacted by material cost increases and  lower tooling profits along with some price concessions to secure long-term supply contracts.

CORPORATE & OTHER

In addition to our three reporting segments, Aptar assigns certain costs to “Corporate & Other,” which is presented separately in Note 15 – Segment Information to the Notes to the Condensed Consolidated Financial Statements. For Corporate & Other, Adjusted EBITDA (which excludes net interest, taxes, depreciation, amortization, restructuring and transaction costs) primarily includes certain professional fees, compensation and information system costs which are not allocated directly to our reporting segments.  For the quarter ended September 30, 2018, Corporate & Other expenses decreased slightly to $8.0 million from $8.8 million.

Corporate & Other expenses in the first nine months of 2018 increased to $28.6 million compared to $26.9 million reported in the same period of the prior year.  This increase is mainly due to increases in advisory, legal and personnel costs.  We also reported a $0.9 million loss on the write-down of an administrative building, which is held for sale, during 2018.

NON-U.S. GAAP MEASURE S

In addition to the information presented herein that conforms to U.S. GAAP, we also present financial information that does not conform to U.S. GAAP, which are referred to as non-U.S. GAAP financial measures. Management may assess our financial results both on a U.S. GAAP basis and on a non-U.S. GAAP basis. We believe it is useful to present these non-U.S. GAAP financial measures because they allow for a better period over period comparison of operating results by removing the impact of items that, in management’s view, do not reflect Aptar’s core operating performance. These non-U.S. GAAP financial measures should not be considered in isolation or as a substitute for U.S. GAAP financial results, but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. Investors are cautioned against placing undue reliance on these non-U.S. GAAP measures. Further, investors are urged to review and consider carefully the adjustments made by management to the most directly comparable U.S. GAAP financial measure to arrive at these non-U.S. GAAP financial measures.

In our Management’s Discussion and Analysis, we exclude the impact of foreign currency translation when presenting net sales information, which we define as “constant currency.” Changes in net sales excluding the impact of foreign currency translation is a non-U.S. GAAP financial measure. As a worldwide business, it is important that we take into account the effects of foreign currency translation when we view our results and plan our strategies. Consequently, when our management looks at our financial results to measure the core performance of our business, we may exclude the impact of foreign currency translation by translating our prior period results at current period foreign currency exchange rates. As a result, our management believes that these presentations are useful internally and may be useful to investors. We also exclude the impact of material acquisitions when comparing results to prior periods.  Changes in operating results excluding the impact of acquisitions are non-U.S. GAAP financial measures.  We believe it is important to exclude the impact of acquisitions on period over period results in order to evaluate performance on a more comparable basis.

We present earnings before net interest and taxes (“EBIT”) and earnings before net interest, taxes, depreciation and amortization (“EBITDA”).  We also present our adjusted earnings before net interest and taxes (“Adjusted EBIT”) and consolidated adjusted earnings before net interest, taxes, depreciation and amortization (“Adjusted EBITDA”), both of which exclude the business transformation charges and acquisition-related costs. Our Outlook is also provided on a non-U.S. GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as tax and exchange rates, or reliably predicted because they are not part of the Company's routine activities, such as restructuring and acquisition-related costs.

Finally, we provide a reconciliation of Net Debt to Net Capital as a non-U.S. GAAP measure.  Net Debt is calculated as interest bearing debt less cash, cash equivalents and short-term investments while Net Capital is calculated as stockholder’s equity plus Net Debt.  Net Debt to Net Capital measures a company’s financial leverage, which gives users an idea of a company's financial structure, or how it is financing its operations, along with insight into its financial strength.  We believe that it is meaningful to take into consideration the balance of our cash, cash equivalents, and short-term investments when evaluating our leverage.  If needed, such assets could be used to reduce our gross debt position.

38


Three Months Ended

September 30, 2018

Consolidated

Beauty + Home

Pharma

Food + Beverage

Corporate & Other

Net Interest

Net Sales

$

665,775

$

341,760

$

227,515

$

96,500

$

-

$

-

Reported net income

$

39,022

Reported income taxes

11,920

Reported income before income taxes

50,942

3,471

67,016

5,481

(17,828)

(7,198)

Adjustments:

Restructuring initiatives

23,852

18,854

2,008

2,638

352

Transaction costs related to acquisitions

7,082

7,082

Purchase accounting adjustments related to acquired companies' inventory

3,287

2,761

526

Adjusted earnings before income taxes

85,163

22,325

71,785

8,645

(10,394)

(7,198)

Interest expense

8,735

8,735

Interest income

(1,537)

(1,537)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

92,361

22,325

71,785

8,645

(10,394)

-

Depreciation and amortization

41,857

19,849

12,731

6,837

2,440

-

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

134,218

$

42,174

$

84,516

$

15,482

$

(7,954)

$

-

Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

20.2%

12.3%

37.1%

16.0%

Three Months Ended

September 30, 2017

Consolidated

Beauty + Home

Pharma

Food + Beverage

Corporate & Other

Net Interest

Net Sales

$

624,326

$

333,748

$

199,547

$

91,031

$

-

$

-

Reported net income

$

53,529

Reported income taxes

15,989

Reported income before income taxes

69,518

21,837

55,426

11,668

(10,793)

(8,620)

Adjustments:

None

Earnings before income taxes

69,518

21,837

55,426

11,668

(10,793)

(8,620)

Interest expense

9,733

9,733

Interest income

(1,113)

(1,113)

Earnings before net interest and taxes (EBIT)

78,138

21,837

55,426

11,668

(10,793)

-

Depreciation and amortization

40,087

20,790

10,834

6,448

2,015

-

Earnings before net interest, taxes, depreciation and amortization (EBITDA)

$

118,225

$

42,627

$

66,260

$

18,116

$

(8,778)

$

-

EBITDA margins (EBITDA / Reported Net Sales)

18.9%

12.8%

33.2%

19.9%

39


Nine Months Ended

September 30, 2018

Consolidated

Beauty + Home

Pharma

Food + Beverage

Corporate & Other

Net Interest

Net Sales

$

2,079,733

$

1,088,469

$

698,851

$

292,413

$

-

$

-

Reported net income

$

154,091

Reported income taxes

52,966

Reported income before income taxes

207,057

40,688

208,915

21,736

(45,834)

(18,448)

Adjustments:

Restructuring initiatives

48,002

38,501

3,596

4,307

1,598

Transaction costs related to acquisitions

9,526

574

8,952

Purchase accounting adjustments related to acquired companies' inventory

3,406

119

2,761

526

Adjusted earnings before income taxes

267,991

79,882

215,272

26,569

(35,284)

(18,448)

Interest expense

24,754

24,754

Interest income

(6,306)

(6,306)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

286,439

79,882

215,272

26,569

(35,284)

-

Depreciation and amortization

123,133

61,273

35,437

19,715

6,708

-

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

409,572

$

141,155

$

250,709

$

46,284

$

(28,576)

$

-

Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

19.7%

13.0%

35.9%

15.8%

Nine Months Ended

September 30, 2017

Consolidated

Beauty + Home

Pharma

Food + Beverage

Corporate & Other

Net Interest

Net Sales

$

1,843,388

$

978,313

$

598,161

$

266,914

$

-

$

-

Reported net income

$

170,523

Reported income taxes

48,043

Reported income before income taxes

218,566

69,248

174,288

31,385

(32,734)

(23,621)

Adjustments:

None

Earnings before income taxes

218,566

69,248

174,288

31,385

(32,734)

(23,621)

Interest expense

25,707

25,707

Interest income

(2,086)

(2,086)

Earnings before net interest and taxes (EBIT)

242,187

69,248

174,288

31,385

(32,734)

-

Depreciation and amortization

114,660

60,017

30,462

18,371

5,810

-

Earnings before net interest, taxes, depreciation and amortization (EBITDA)

$

356,847

$

129,265

$

204,750

$

49,756

$

(26,924)

$

-

EBITDA margins (EBITDA / Reported Net Sales)

19.4%

13.2%

34.2%

18.6%

40


Net Debt to Net Capital Reconciliation

September 30,

December 31,

2018

2017

Notes payable, including revolving credit facilities

$

153,236

$

4,336

Current maturities of long-term obligations, net of unamortized debt issuance costs

64,039

61,833

Long-Term Obligations, net of unamortized debt issuance costs

1,131,737

1,191,146

Total Debt

1,349,012

1,257,315

Less:

Cash and equivalents

291,382

712,640

Net Debt

$

1,057,630

$

544,675

Total Stockholders' Equity

$

1,392,058

$

1,312,048

Net Debt

1,057,630

544,675

Net Capital

$

2,449,688

$

1,856,723

Net Debt to Net Capital

43.2%

29.3%

FOREIGN CURRENCY

Because of our international presence, movements in exchange rates may have a significant impact on the translation of the financial statements of our foreign subsidiaries.  Our primary foreign exchange exposure is to the euro, but we also have foreign exchange exposure to the Chinese yuan, Brazilian real, Mexican peso, Swiss franc and other Asian, European and South American currencies.  A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on our financial statements.  Conversely, a weakening U.S. dollar has an additive effect.  In some cases, we sell products denominated in a currency different from the currency in which the related costs are incurred.  We manage our exposures to foreign exchange principally with forward exchange contracts to economically hedge recorded transactions and firm purchase and sales commitments denominated in foreign currencies.  Changes in exchange rates on such inter-country sales could materially impact our results of operations.  During the third quarter of 2018 the U.S. dollar strengthened compared to the Euro.  This resulted in a dilutive impact on our translated results during the third quarter of 2018 when compared to the third quarter of 2017. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Our Argentinian operations contributed approximately 2.0% of consolidated net assets and revenues at and for the nine months ended September 30, 2018.

QUARTERLY TRENDS

Our results of operations in the last quarter of the year typically are negatively impacted by customer plant shutdowns in December.  In the future, our results of operations in a quarterly period could be impacted by factors such as the seasonality of certain products within our segments, changes in foreign currency rates, changes in product mix, changes in material costs, changes in growth rates in the markets to which our products are sold, recognition of equity-based compensation expense for retirement eligible employees in the period of grant and changes in general economic conditions in any of the countries in which we do business.

We generally incur higher employee stock option expense in the first quarter compared with the rest of the fiscal year.  Our estimated total stock-based compensation expense on a pre-tax basis (in $ millions) for the year 2018 compared to 2017 is as follows:

2018

2017

First Quarter

$

7.5

$

7.8

Second Quarter

3.4

3.9

Third Quarter

3.9

3.3

Fourth Quarter (estimated for 2018)

4.7

3.9

$

19.5

$

18.9

41


LIQUIDITY AND CAPITAL RESOURCES

We believe we are in a strong financial position and have the financial resources to meet our business requirements in the foreseeable future. We have historically used cash flow from operations, our revolving credit facilities, stock option exercises and debt, as needed, as our primary sources of liquidity.  Our primary uses of liquidity are to invest in equipment and facilities that are necessary to support our growth and to make acquisitions that will contribute to the achievement of our strategic objectives. Other uses of liquidity include repurchasing shares of our common stock and paying dividends to stockholders. On October 18, 2018, the Board of Directors declared a quarterly cash dividend of $0.34 per share payable on November 21, 2018 to stockholders of record as of October 31, 2018. In the event that customer demand would decrease significantly for a prolonged period of time and negatively impact cash flow from operations, we would have the ability to restrict and significantly reduce capital expenditure levels, as well as evaluate our acquisition strategy and dividend and share repurchase programs.  A prolonged and significant reduction in capital expenditure levels could increase future repairs and maintenance costs as well as have a negative impact on operating margins if we were unable to invest in new innovative products.

During 2017, we voluntarily repatriated approximately $1.0 billion from Europe to the U.S. This was achieved through a combination of surplus available cash and raising debt in our UK subsidiary in Europe.  This gave us full financial flexibility to utilize the repatriated cash to meet our U.S. funding needs and for strategic business investments, including the recent acquisition of CSP Technologies.  Adding euro-denominated debt better aligns our capital structure with our euro earnings base, and we were able to take advantage of historically low euro debt interest rates. At September 30, 2018, our weighted-average debt interest rate is 2.66%, and the mix of our fixed to floating debt is 90:10.

Cash and equivalents decreased to $291.4 million at September 30, 2018 from $712.6 million at December 31, 2017 primarily due to the acquisition of CSP Technologies.  Total short and long-term interest bearing debt of $1.3 billion at September 30, 2018 was at the same level as December 31, 2017.  Due to the decrease in cash to fund our CSP Technologies acquisition, the ratio of our Net Debt (interest bearing debt less cash and cash equivalents) to Net Capital (stockholders’ equity plus Net Debt) increased to 43.2% at September 30, 2018 compared to 29.3% at December 31, 2017. See the reconciliation of non-U.S. GAAP measures starting on page 38

In the first nine months of 2018, our operations provided approximately $209.6 million in net cash flow compared to $265.2 million for the same period a year ago.  In both periods, cash flow from operations was primarily derived from earnings before depreciation and amortization.  The decrease in cash provided by operations is primarily attributable to a decrease in net income from our business transformation expenses.

We used $668.7 million in cash for investing activities during the first nine months of 2018 compared to $189.2 million during the same period a year ago. Approximately $553.5 million of our cash (exclusive of $24.1 million of cash acquired) was utilized to fund our acquisition of CSP Technologies during 2018. $5.0 million is currently held in restricted cash pending the finalization of a working capital adjustment expected to be completed within 75 days after closing. We also invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health, which is accounted for at cost, and acquired Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets, for an initial purchase price of approximately $3.6 million (exclusive of $112 thousand of cash acquired). Our investment in capital projects increased $24.5 million for the first nine months of 2018 compared to the first nine months of 2017 to support the growth of our business. Our 2018 estimated cash outlays for capital expenditures are expected to be in the range of approximately $190 to $210 million but could vary due to changes in exchange rates as well as the timing of capital projects.  The increase in cash used for investing activities during the first nine months of 2018 was partially offset by the receipt of $10.6 million of insurance proceeds related to the Annecy fire property damages. In 2017, we also invested $5.0 million for a 20% minority investment in a technology company which provides digital monitoring systems for medical devices.

Financing activities provided $50.3 million in cash during the first nine months of 2018 compared to $447.3 million during the same period a year ago.  During the first nine months of 2018, we received net proceeds from our short term credit facility and stock option exercises of $139.4 million and $78.9 million, respectively. We used cash on hand to repay $67.0 million of long-term debt, pay $61.0 million of dividends and repurchase $61.7 million of common stock.  Following the repatriation in 2017 of $1.0 billion from Europe to the U.S., these funds were used to repay $160 million outstanding on the U.S. revolving credit facility and repurchase $113.3 million of common stock.

42


On July 20, 2017, the Company replaced its $300 million revolving credit facility with a new 5-year multi-currency revolving credit facility with two tranches, providing for unsecured financing of up to $300 million that is available in the U.S. and up to €150 million that is available to our wholly-owned UK subsidiary. Each borrowing under the credit facility will bear interest at rates based on LIBOR, prime rates or other similar rates, in each case plus an applicable margin. A facility fee on the total amount of the facility is also payable quarterly, regardless of usage. The applicable margins for borrowings under the credit facility and the facility fee percentage may change from time to time depending on changes in Aptar’s consolidated leverage ratio. We utilized $35.0 million of the U.S. credit facility and €89.5 million of the UK subsidiary credit facility at September 30, 2018 and had no outstanding balance at December 31, 2017.  We incurred approximately $850 thousand and $734 thousand in interest and fees related to our credit facilities during the nine months ended September 30, 2018 and 2017, respectively.

Our revolving credit facility and corporate long-term obligations require us to satisfy certain financial and other covenants including:

Requirement

Level at September 30, 2018

Consolidated Leverage Ratio (1)

Maximum of 3.50 to 1.00

2.05 to 1.00

Consolidated Interest Coverage Ratio (1)

Minimum of 3.00 to 1.00

12.36 to 1.00


(1)

Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements.

Based upon the above consolidated leverage ratio covenant, we have the ability to borrow approximately an additional $773 million before the 3.50 to 1.00 maximum ratio requirement is exceeded.

Our foreign operations have historically met cash requirements with the use of internally generated cash or uncommitted short-term borrowings.  We also have committed financing arrangements in both the U.S. and UK as detailed above.  We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances.

During the third quarter of 2017, the Company entered into the borrowing arrangements summarized below through our wholly-owned UK subsidiary to better balance our capital structure.

Debt type

Amount

Term/Maturity

Interest rate

Bank term loan

$280 million

5 year amortizing/July 2022

2.56% floating swapped to 1.36% fixed

Bank revolver

€150 million

5 year/July 2022

1.10% floating

Private placement

€100 million

6 year/July 2023

0.98% fixed

Private placement

€200 million

7 year/July 2024

1.17% fixed

Aptar also entered into a EUR/USD floating-to-fixed cross currency swap on July 20, 2017 to mitigate the currency risk of U.S. dollar debt on a euro functional currency entity and to also mitigate the risk of variability in interest rates on the $280 million bank term loan. The Company expects its future European cash flows will be sufficient to service this new debt.

CONTINGENCIES

The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature.  Please refer to Note 11 - Commitments and Contingencies of the Notes to Condensed Consolidated Financial Statements for a discussion of contingencies affecting the Company’s business.

OFF-BALANCE SHEET ARRANGEMENTS

We lease certain warehouse, plant and office facilities as well as certain equipment under noncancelable operating leases expiring at various dates through the year 2027.  Most of the operating leases contain renewal options and certain equipment leases include options to purchase during or at the end of the lease term.  Other than operating lease obligations, we do not have any off-balance sheet arrangements.

RECENTLY ISSUED ACCOUNTING STANDARDS

We have reviewed the recently issued accounting standards updates to the FASB’s Accounting Standards Codification that have future effective dates.  Standards that are effective for 2018 are discussed in Note 1 – Summary of Significant Accounting Policies of the Notes to Condensed Consolidated Financial Statements.

43


In February 2016, the FASB issued ASU 2016-02 and subsequent amendments, which requires organizations to recognize leases on the balance sheet, and disclose key information about leasing arrangements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and recognition of expense in the income statement. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. We expect to adopt the new standard on its effective date. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. We expect to adopt the new standard on January 1, 2019 and use the effective date (option 1) as our date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The new standard also provides practical expedients for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. While we continue to assess all of the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our operating leases and the significant new disclosures about our leasing activities.

In June 2016, the FASB issued ASU 2016-13, which changes the accounting guidance for measurement of credit losses on financial instruments. The guidance replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information when recording credit loss estimates.  The new standard is effective for fiscal years and interim periods beginning after December 15, 2019.  The Company is currently evaluating the impact of adopting this guidance.

In January 2017, the FASB issued ASU 2017-04, which provides guidance to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As a result, impairment charges will be required for the amount by which a reporting units carrying amount exceeds its fair value up to the amount of its allocated goodwill. The new standard is effective for the annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company does not believe that this new guidance will have a material impact on its Condensed Consolidated Financial Statements.

In February 2018, the FASB issued ASU 2018-02, which provides guidance on the reclassification of certain tax effects from accumulated other comprehensive income.  This guidance allows for the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the TCJA.  The new standard is effective for fiscal years and interim periods beginning after December 15, 2018.  The Company is currently evaluating the impact of adopting this guidance.

In August 2018, the FASB issued ASU 2018-14, which amends disclosure requirements for defined benefit pension and other postretirement plans.  The amendments in this update remove disclosures that no longer are considered cost beneficial, clarify the specific requirements of disclosures, and add disclosure requirements identified as relevant. The new standard is effective for fiscal years ending after December 15, 2020.  As this update amends disclosure requirements, the Company does not expect any significant impact around adopting this guidance.

In August 2018, the FASB issued ASU 2018-15 to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license.  The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Accordingly, the amendments require an entity (customer) in a hosting arrangement that is a service contract to follow the guidance in Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The amendments also require the entity (customer) to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, which includes reasonably certain renewals. The new standard is effective for fiscal years beginning after December 15, 2019.  The Company is currently evaluating the impact of adopting this guidance.

Other accounting standards that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our Condensed Consolidated Financial Statements upon adoption.

44


OUTLOOK

For the fourth quarter, we expect continued core sales growth in each segment over the prior year in spite of difficult comparisons to our very strong prior year fourth quarter, where each segment posted double digit core sales growth. However, we expect the inflationary environment to continue and raw material and transportation costs are expected to weigh on margins due to the normal delay in passing on these increased costs. Further, we anticipate isolated weaker beverage volumes in China.  We expect earnings per share for the fourth quarter, excluding any restructuring and acquisition costs, to be in the range of $0.81 to $0.86. This guidance is based on an effective tax rate range of 30% to 32%. Prior year reported earnings per share of $0.77 included a gain on insurance recovery of $0.11 per share, restructuring expenses of $0.03 per share and the $0.12 per share impact of the tax reform legislation enacted in the fourth quarter of last year. Excluding these effects and adjusting for comparable exchange rates, which had a positive impact of $0.03 per share, prior year adjusted earnings per share were $0.78. Prior year adjusted earnings per share would have been approximately $0.07 lower had our current effective tax rate been applied to prior year adjusted earnings.

FORWARD-LOOKING STATEMENTS

Certain statements in Management’s Discussion and Analysis and other sections of this Form 10-Q are forward-looking and involve a number of risks and uncertainties, including certain statements set forth in the Restructuring Initiatives, Quarterly Trends, Liquidity and Capital Resources, Contingencies and Outlook sections of this Form 10-Q. Words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”) and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to:

·

economic conditions worldwide, including potential deflationary and inflationary conditions in regions we rely on for growth;

·

political conditions worldwide;

·

the impact of tax reform legislation, changes in tax rates and other tax-related events or transactions that could impact our effective tax rate;

·

significant fluctuations in foreign currency exchange rates;

·

financial conditions of customers and suppliers;

·

consolidations within our customer or supplier bases;

·

changes in customer and/or consumer spending levels;

·

loss of one or more key accounts;

·

the availability of raw materials and components (particularly from sole sourced suppliers) as well as the financial viability of these suppliers;

·

fluctuations in the cost of materials, components and other input costs (particularly resin, metal, anodization costs and transportation and energy costs);

·

the impact and extent of contamination found at the Company’s facility in Brazil;

·

our ability to successfully implement facility expansions and new facility projects;

·

the impact of the UK leaving the European Union (Brexit) on our UK operations;

·

our ability to offset inflationary impacts with cost containment, productivity initiatives or price increases;

·

changes in capital availability or cost, including interest rate fluctuations;

·

volatility of global credit markets;

·

the timing and magnitude of capital expenditures;

·

our ability to identify potential new acquisitions and to successfully acquire and integrate such operations or products, including the successful integration of the CSP Technologies business;

·

direct or indirect consequences of acts of war, terrorism or social unrest;

·

cybersecurity threats that could impact our networks and reporting systems;

·

the impact of natural disasters and other weather-related occurrences;

·

fiscal and monetary policies and other regulations;

·

changes or difficulties in complying with government regulation;

·

changing regulations or market conditions regarding environmental sustainability;

·

work stoppages due to labor disputes;

·

competition, including technological advances;

·

our ability to protect and defend our intellectual property rights, as well as litigation involving intellectual property rights;

·

the outcome of any legal proceeding that has been or may be instituted against us and others;

·

our ability to meet future cash flow estimates to support our goodwill impairment testing;

·

the demand for existing and new products;

45


·

the success of our customers’ products, particularly in the pharmaceutical industry;

·

our ability to manage worldwide customer launches of complex technical products, particularly in developing markets;

·

difficulties in product development and uncertainties related to the timing or outcome of product development;

·

significant product liability claims;

·

the successful execution of our business transformation; and

·

other risks associated with our operations.

Although we believe that our forward-looking statements are based on reasonable assumptions, there can be no assurance that actual results, performance or achievements will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements.  We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.  Please refer to Item 1A (“Risk Factors”) of Part I included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 for additional risk factors affecting the Company.

46


ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

A significant number of our operations are located outside of the United States.  Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of our entities.  Our primary foreign exchange exposure is to the euro, but we also have foreign exchange exposure to the Chinese yuan, Brazilian real, Mexican peso and Swiss franc, among other Asian, European, and South American currencies. A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on our financial condition and results of operations.  Conversely, a weakening U.S. dollar relative to foreign currencies has an additive translation effect on our financial condition and results of operations.

Additionally, in some cases, we sell products denominated in a currency different from the currency in which the related costs are incurred.  Any changes in exchange rates on such inter-country sales may impact our results of operations.

We manage our exposures to foreign exchange principally with forward exchange contracts to hedge certain firm purchase and sales commitments and intercompany cash transactions denominated in foreign currencies.

The table below provides information as of September 30, 2018 about our forward currency exchange contracts.  The majority of the contracts expire before the end of the fourth quarter of 2018.

Average

Min / Max

Contract Amount

Contractual

Notional

Buy/Sell

(in thousands)

Exchange Rate

Volumes

CHF / EUR

$

42,289

0.8877

42,289-52,933

EUR / USD

20,127

1.1720

14,422-20,555

EUR / BRL

17,475

4.7533

14,938-17,475

USD / EUR

8,289

0.8544

6,383-8,289

COP / USD

5,626

0.0003

5,520-5,934

EUR / INR

5,030

82.3400

5,030-6,195

EUR / IDR

2,298

19.2090

2,181-2,298

EUR / MXN

948

22.3549

934-948

USD / MXN

720

18.8954

630-720

USD / COP

664

2,958.8500

664-1,420

EUR / CHF

402

1.1287

64-11,384

USD / CHF

10

0.9634

0-10

Total

$

103,878

As of September 30, 2018, the Company has recorded the fair value of foreign currency forward exchange contracts of $0.3 million in prepaid and other and $0.9 million in accounts payable and accrued liabilities on the balance sheet. Aptar also entered into a EUR/USD floating-to-fixed cross currency swap on July 20, 2017 to effectively hedge the foreign exchange and interest rate exposure on the $280 million bank term loan drawn by its wholly-owned UK subsidiary.  The fair value of this cash flow hedge is $4.7 million and is reported in accounts payable and accrued liabilities on the balance sheet.

ITEM 4.  CONTROLS AND PROCEDURES

DISCLOSURE CONTROLS AND PROCEDURES

The Company’s management has evaluated, with the participation of the chief executive officer and chief financial officer of the Company, the effectiveness of the Company’s disclosure controls and procedures (as that term is defined in Rule 13a-15(e) under the Exchange Act) as of September 30, 2018.  Based on that evaluation, the chief executive officer and chief financial officer have concluded that these controls and procedures were effective as of such date.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

During the quarter ended September 30, 2018, the Company implemented enterprise resource planning (“ERP”) systems at two operating facilities.  Consequently, the control environments have been modified at these locations to incorporate the controls contained within the new ERP system.  Other than these items, no changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) occurred during the Company’s fiscal quarter ended September 30, 2018 that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

47


PART II - OTHER INFORMATION

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

RECENT SALES OF UNREGISTERED SECURITIES

Certain French employees are eligible to participate in the FCP Aptar Savings Plan (the “Plan”).  An independent agent purchases shares of common stock available under the Plan for cash on the open market and we do not issue shares.  We do not receive any proceeds from the purchase of common stock under the Plan.  The agent under the Plan is Banque Nationale de Paris Paribas Fund Services.  No underwriters are used under the Plan.  All shares are sold in reliance upon the exemption from registration under the Securities Act of 1933 provided by Regulation S promulgated under that Act.  During the quarter ended September 30, 2018, the Plan purchased no shares of our common stock on behalf of the participants, and sold 3,524 shares of our common stock on behalf of the participants at an average price of $104.67, for an aggregate amount of $369 thousand.  At September 30, 2018, the Plan owned 76,127 shares of our common stock.

ISSUER PURCHASES OF EQUITY SECURITIES

On October 20, 2016, the Company announced a share repurchase authorization of up to $350 million of common stock.  This authorization replaces previous authorizations and has no expiration date.  Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.

The Company did not repurchase any shares during the third quarter of 2018.

The following table summarizes the Company’s purchases of its securities for the quarter ended September 30, 2018:

Dollar Value Of

Total Number Of Shares

Shares that May Yet be

Total Number

Purchased as Part Of

Purchased Under The

Of Shares

Average Price

Publicly Announced

Plans or Programs

Period

Purchased

Paid Per Share

Plans Or Programs

(in millions)

7/1 – 7/31/18

$

$

80.2

8/1 – 8/31/18

80.2

9/1 – 9/30/18

80.2

Total

$

$

80.2

48


ITEM 6.  EXHIBITS

Exhibit 2.1

Offer Letter, dated as of July 26, 2018, among AptarGroup, Inc., CSP Technologies Parent S.A., Expansion 17 S.C.A. SICAR and Global Performance 17 S.C.A. SICAR. †

Exhibit 2.2

Stock Purchase Agreement, dated as of July 26, 2018, by and between AptarGroup, Inc., and CSP Technologies Parent S.A. †

Exhibit 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.2

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 101

The following financial information from our Quarterly Report on Form 10-Q for the third quarter of fiscal 2018, filed with the SEC on November 5, 2018, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income – Three and Nine Months Ended September 30, 2018 and 2017, (ii) the Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended September 30, 2018 and 2017, (iii) the Condensed Consolidated Balance Sheets – September 30, 2018 and December 31, 2017, (iv) the Condensed Consolidated Statements of Changes in Equity – Three and Nine Months Ended September 30, 2018 and 2017, (v) the Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2018 and 2017 and (vi) the Notes to Condensed Consolidated Financial Statements.

† The exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2).  The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.

49


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AptarGroup, Inc.

(Registrant)

By

/s/ ROBERT W. KUHN

Robert W. Kuhn

Executive Vice President,

Chief Financial Officer and Secretary

(Duly Authorized Officer and

Principal Accounting and Financial Officer)

Date: November 5, 2018

50


TABLE OF CONTENTS
Part I Financial InformationprintItem 1. Financial Statements (unaudited)printNote 1 Summary Of Significant Accounting PoliciesprintNote 2 RevenueprintNote 3 - InventoriesprintNote 4 Goodwill and Other Intangible AssetsprintNote 5 Income TaxesprintNote 7 Retirement and Deferred Compensation PlansprintNote 8 Accumulated Other Comprehensive IncomeprintNote 9 Derivative Instruments and Hedging ActivitiesprintNote 10 Fair ValueprintNote 11 - Commitments and ContingenciesprintNote 12 Stock Repurchase ProgramprintNote 13 Stock-based CompensationprintNote 14 Earnings Per ShareprintNote 15 Segment InformationprintNote 16 Insurance Settlement ReceivableprintNote 17 AcquisitionsprintNote 18 Restructuring InitiativesprintItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintPart II - Other InformationprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 6. Exhibitsprint

Exhibits

Exhibit 2.1 Offer Letter, dated as of July 26, 2018, among AptarGroup, Inc., CSP Technologies Parent S.A., Expansion 17 S.C.A. SICAR and Global Performance 17 S.C.A. SICAR. Exhibit 2.2 Stock Purchase Agreement, dated as of July 26, 2018, by and between AptarGroup, Inc., and CSP Technologies Parent S.A. Exhibit31.1 Certification Pursuant to Section302 of the Sarbanes-Oxley Act of 2002. Exhibit31.2 Certification Pursuant to Section302 of the Sarbanes-Oxley Act of 2002. Exhibit32.1 Certification Pursuant to 18 U.S.C. Section1350, as Adopted Pursuant to Section906 of the Sarbanes-Oxley Act of 2002. Exhibit32.2 Certification Pursuant to 18 U.S.C. Section1350, as Adopted Pursuant to Section906 of the Sarbanes-Oxley Act of 2002.